Archives of Toxicology

, Volume 85, Issue 11, pp 1313–1359 | Cite as

Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds

Review Article


The advance in the area of synthesis and reactivity of organoselenium, as well as the discovery that selenium was the cause of severe intoxication episodes of livestock in the 1930s and the subsequent determination that selenium was an essential trace element in the diet for mammals, has motivated intense studies of the biological properties of both organic and inorganic selenium compounds. In this review, we shall cover a wide range of toxicological and pharmacological effects, in which organoselenium compounds are involved but the effects of inorganic compounds were not discussed in detail here. The molecular toxicity of inorganic selenium was described in relation to its interaction with endogenous –SH groups to allow a comparison with that of synthetic organoselenium compounds. Furthermore, in view of the recent points of epidemiological evidence that overexposure to selenium can facilitate the appearance of chronic degenerative diseases, we also briefly revised the history of selenium toxicity and physiology and how environmental selenium can reach inside the mammalian cells. The biological narrative of the element selenium, in the last century, has been marked by a contrast between its toxic and its beneficial effects. Thus, the potential therapeutic use of simple organoselenium compounds has not yet been sufficiently explored and, consequently, we cannot discard this class of compounds as promising pharmaceutical agents. In effect, the future of the organochalcogens as pharmacological agents will depend on more detailed toxicological studies in the oncoming years.


Selenium Diselenides Toxicology Pharmacology Thiol Organoselenium Ebselen Oxidative stress 


  1. Acker CI, Brandão R, Rosário AR, Nogueira CW (2009a) Antioxidant effect of alkynylselenoalcohol compounds on liver and brain of rats in vitro. Environ Toxicol Pharmacol 28:280–287PubMedCrossRefGoogle Scholar
  2. Acker CI, Luchese C, Prigol M, Nogueira CW (2009b) Antidepressant-like effect of diphenyl diselenide on rats exposed to malathion: involvement of Na+K+ ATPase activity. Neurosci Lett 455:168–172PubMedCrossRefGoogle Scholar
  3. Adams WJ, Kocsis JJ, Snyder R (1989) Acute toxicity and urinary excretion of diphenyldiselenide. Toxicol Lett 48:301–310PubMedCrossRefGoogle Scholar
  4. Akerboom TPM, Sies H, Ziegler DM (1995) The oxidation of ebselen metabolites to thiol oxidants catalyzed by liver-microsomes and perfused-rat-liver. Arch Biochem Biophys 316:220–226PubMedCrossRefGoogle Scholar
  5. Alberto EE, Soares LC, Sudati JH, Borges ACA, Rocha JBT, Braga AL (2009) Efficient synthesis of modular amino acid derivatives containing selenium with pronounced GPx like activity. Eur J Org Chem 4211–4214Google Scholar
  6. Ali N, Yoshizumi M, Tsuchiya K, Kyaw M, Fujita Y, Izawa Y, Abe S, Kanematsu Y, Kagami S, Tamaki T (2004) Ebselen inhibits p38 mitogen-activated protein kinase-mediated endothelial cell death by hydrogen peroxide. Eur J Pharmacol 485:127–135PubMedCrossRefGoogle Scholar
  7. Allmang C, Krol A (2006) Selenoprotein synthesis: UGA does not end the story. Biochimie 88:1561–1571PubMedCrossRefGoogle Scholar
  8. Allmang C, Wurth L, Krol A (2009) The selenium to selenoprotein pathway in eukaryotes: More molecular partners than anticipated. Biochim Biophys Acta-gen Subj 1790:1415–1423CrossRefGoogle Scholar
  9. Andersson CM, Hallberg A, Linden M, Brattsand R, Moldeus P, Cotgreave I (1994) Antioxidant activity of some diarylselenides in biological systems. Free Radic Biol Med 16:17–28PubMedCrossRefGoogle Scholar
  10. Araie H, Shiraiwa Y (2009) Selenium utilization strategy by microalgae. Molecules 14:4880–4891PubMedCrossRefGoogle Scholar
  11. Arakawa M, Ishimura A, Arai Y, Kawabe K, Suzuki S, Ishige K, Ito Y (2007) N-Acetylcysteine and ebselen but not nifedipine protected cerebellar granule neurons against 4-hydroxynonenal-induced neuronal death. Neurosci Res 57:220–229PubMedCrossRefGoogle Scholar
  12. Arner ESJ (2010) Selenoproteins—what unique properties can arise with selenocysteine in place of cysteine? Exp Cell Res 316:1296–1303PubMedCrossRefGoogle Scholar
  13. Arner ESJ, Holmgren A (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267:6102–6109PubMedCrossRefGoogle Scholar
  14. Arteel GE, Sies H (2001) The biochemistry of selenium and the glutathione system. Environ Toxicol Phar 10:153–158CrossRefGoogle Scholar
  15. Arteel GE, Briviba K, Sies H (1999) Function of thioredoxin reductase as a peroxynitrite reductase using selenocystine or ebselen. Chem Res Toxicol 12:264–269PubMedCrossRefGoogle Scholar
  16. Aruoma OI (1997) Scavenging of hypochlorous acid by carvedilol and ebselen in vitro. Gen Pharmacol 28:269–272PubMedCrossRefGoogle Scholar
  17. Assmann A, Briviba K, Sies H (1998) Reduction of methionine selenoxide to selenomethionine by glutathione. Arch Biochem Biophys 349:201–203PubMedCrossRefGoogle Scholar
  18. Assmann A, Bonifacic M, Briviba K, Sies H (2000) One-electron reduction of selenomethionine oxide. Free Radical Res 32:371–376CrossRefGoogle Scholar
  19. Ayhanci A, Yaman S, Appak S, Gunes S (2009) Hematoprotective effect of selenomethionine on cyclophosphamide toxicity in rats. Drug Chem Toxicol 32:424–428PubMedCrossRefGoogle Scholar
  20. Azrak RG, Yu J, Pendyala L, Smith PF, Cao SS, Li X, Shannon WD, Durrani FA, McLeod HL, Rustum YM (2005) Irinotecan pharmacokinetic and pharmacogenomic alterations induced by methylselenocysteine in human head and neck xenograft tumors. Mol CancerTher 4:843–854CrossRefGoogle Scholar
  21. Azrak RG, Cao S, Pendyala L, Durrani FA, Fakih M, Combs GF Jr, Prey J, Smith PF, Rustum YM (2007) Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent. Biochem Pharmacol 73:1280–1287PubMedCrossRefGoogle Scholar
  22. Back TG, Dick BP (1997) A novel camphor-derived selenamide that acts as a glutathione peroxidase mimetic. J Am Chem Soc 119:2079–2083CrossRefGoogle Scholar
  23. Back TG, Moussa Z (2002) Remarkable activity of a novel cyclic seleninate ester as a glutathione peroxidase mimetic and its facile in situ generation from allyl 3-hydroxypropyl selenide. J Am Chem Soc 124:12104–12105PubMedCrossRefGoogle Scholar
  24. Back TG, Moussa Z (2003) Diselenides and allyl selenides as glutathione peroxidase mimetics. Remarkable activity of cyclic seleninates produced in situ by the oxidation of allyl omega-hydroxyalkyl selenides. J Am Chem Soc 125:13455–13460PubMedCrossRefGoogle Scholar
  25. Back TG, Moussa Z, Parvez M (2004) The exceptional glutathione peroxidase-like activity of di(3-hydroxypropyl) selenide and the unexpected role of a novel spirodioxaselenanonane intermediate in the catalytic cycle. Angew Chem Int Ed 43:1268–1270CrossRefGoogle Scholar
  26. Barbosa NBV, Roch JBT, Beque M, Emanuelli T, Zeni G, Braga AL (1998) Effect of organic forms of selenium on delta-aminolevulinate dehydratase from liver, kidney, and brain of adult rats. Toxicol Appl Pharmacol 149:243–253PubMedCrossRefGoogle Scholar
  27. Barbosa NBV, Rocha JBT, Wondracek DC, Perottoni J, Zeni G, Nogueira CW (2006) Diphenyl diselenide reduces temporarily hyperglycemia: possible relationship with oxidative stress. Chem Biol Interact 163:230–238PubMedCrossRefGoogle Scholar
  28. Barbosa NBD, Nogueira CW, Guecheva TN, Bellinaso MD, Rocha JBT (2008a) Diphenyl diselenide supplementation delays the development of N-nitroso-N-methylurea-induced mammary tumors. Arch Toxicol 82:655–663CrossRefGoogle Scholar
  29. Barbosa NBD, Oliveira C, Araldi D, Folmer V, Rocha JBT, Nogueira CW (2008b) Acute diphenyl diselenide treatment reduces hyperglycemia but does not change delta-aminolevulinate dehydratase activity in alloxan-induced diabetes in rats. Biol Pharm Bull 31:2200–2204PubMedCrossRefGoogle Scholar
  30. Barbosa NBV, Rocha JBT, Soares JCM, Wondracek DC, Gonçalves JF, Schetinger MRC, Nogueira CW (2008c) Dietary diphenyl diselenide reduces the STZ-induced toxicity. Food Chem Toxicol 46:186–194PubMedCrossRefGoogle Scholar
  31. Bechara EJH (1996) Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid. Braz J Med Biol Res 29:841–851PubMedGoogle Scholar
  32. Beil W, Staar U, Sewing KF (1990) Interaction of the anti-inflammatory seleno-organic compound ebselen with acid secretion in isolated parietal cells and gastric H+/K+-ATPase. Biochem Pharmacol 40:1997–2003PubMedCrossRefGoogle Scholar
  33. Benton D (2002) Selenium intake, mood and other aspects of psychological functioning. Nutr Neurosci 5:363–374PubMedCrossRefGoogle Scholar
  34. Benton D, Cook R (1991) The impact of selenium supplementation on mood. Biol Psychiatry 29:1092–1098PubMedCrossRefGoogle Scholar
  35. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A (2000) Cognitive decline is associated with systemic oxidative stress: the EVA study. J Am Geriatrics Soc 48:1285–1291Google Scholar
  36. Bhabak KP, Mugesh G (2007) Synthesis, characterization, and antioxidant activity of some ebselen analogues. Chem Eur J 13:4594–4601CrossRefGoogle Scholar
  37. Bhabak KP, Mugesh G (2008) A simple and efficient strategy to enhance the antioxidant activities of amino-substituted glutathione peroxidase mimics. Chem Eur J 14:8640–8651CrossRefGoogle Scholar
  38. Bhabak KP, Mugesh G (2009a) Amide-based glutathione peroxidase mimics: effect of secondary and tertiary amide substituents on antioxidant activity. Chem Asian J 4:974–983PubMedCrossRefGoogle Scholar
  39. Bhabak KP, Mugesh G (2009b) Synthesis and structure-activity correlation studies of secondary- and tertiary-amine-based glutathione peroxidase mimics. Chem Eur J 15:9846–9854CrossRefGoogle Scholar
  40. Bhabak KP, Mugesh G (2010) Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Acc Chem Res 43:1408–1419PubMedCrossRefGoogle Scholar
  41. Biguet C, Wakasugi N, Mishal Z, Holmgren A, Chouaib S, Tursz T, Wakasugi H (1994) Thioredoxin increases the proliferation of human b-cell lines through a protein-kinase c-dependent mechanism. J Biol Chem 269:28865–28870PubMedGoogle Scholar
  42. Björnstedt M, Kumar S, Holmgren A (1992) Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. J Biol Chem 267:8030–8034PubMedGoogle Scholar
  43. Björnstedt M, Kumar S, Björkhem L, Spyrou G, Holmgren A (1997) Selenium and the thioredoxin and glutaredoxin systems. Biomed Envirom Sci 10:271–279Google Scholar
  44. Bleys J, Navas-Acien A, Guallar E (2007a) Selenium and diabetes: more bad news for supplements. Ann Int Med 147:271–272PubMedGoogle Scholar
  45. Bleys J, Navas-Acien A, Guallar E (2007b) Serum selenium and diabetes in US adults. Diabetes Care 30:829–834PubMedCrossRefGoogle Scholar
  46. Bock A, Forchhammer K, Heider J, Leinfelder W, Sawers G, Veprek B, Zinoni F (1991) Selenocysteine—the 21st amino-acid. Mol Microbiol 5:515–520PubMedCrossRefGoogle Scholar
  47. Bolzan RC, Folmer V, Farina M, Zeni G, Nogueira CW, Rocha JBT, Emanuelli T (2002) Delta-Aminolevulinate dehydratase inhibition by phenyl selenoacetylene: effect of reaction with hydrogen peroxide. Pharmacol Toxicol 90:214–219PubMedCrossRefGoogle Scholar
  48. Bonvicini F, Vinceti M, Marcello N, Rodolfi R, Rinaldi M (2008) The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy. Amyotr Lateral Sclerosis 9:350–353CrossRefGoogle Scholar
  49. Borges LP, Borges VC, Moro AV, Nogueira CW, Rocha JBT, Zeni G (2005a) Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology 210:1–8PubMedCrossRefGoogle Scholar
  50. Borges VC, Rocha JBT, Nogueira CW (2005b) Effect of diphenyl diselenide, diphenyl ditelluride and ebselen on cerebral Na+, K+-ATPase activity in rats. Toxicology 215:191–197PubMedCrossRefGoogle Scholar
  51. Borges LP, Nogueira CW, Panatieri RB, Rocha JBT, Zeni G (2006) Acute liver damage induced by 2-nitropropane in rats: effect of diphenyl diselenide on antioxidant defenses. Chem Biol Interact 160:99–107PubMedCrossRefGoogle Scholar
  52. Borges LP, Brandão R, Godoi B, Nogueira CW, Zeni G (2008) Oral administration of diphenyl diselenide protects against cadmium-induced liver damage in rats. Chem Biol Interact 171:15–25PubMedCrossRefGoogle Scholar
  53. Brandao R, Acker CI, Leite MR, Barbosa NBV, Nogueira CW (2009) Diphenyl diselenide protects against glycerol induced renal damage in rats. J Appl Toxicol 29:612–618PubMedCrossRefGoogle Scholar
  54. Bredt DS, Snyder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175–195PubMedCrossRefGoogle Scholar
  55. Brito VB, Folmer V, Puntel GO, Fachinetto R, Soares JC, Zeni G, Nogueira CW, Rocha JB (2006) Diphenyl diselenide and 2, 3-dimercaptopropanol increase the PTZ-induced chemical seizure and mortality in mice. Brain Res Bull 68:414–418PubMedCrossRefGoogle Scholar
  56. Brito VB, Rocha JB, Folmer V, Erthal F (2009) Diphenyl diselenide and diphenyl ditelluride increase the latency for 4-aminopyridine-induced chemical seizure and prevent death in mice. Acta Biochim Pol 56:125–134PubMedGoogle Scholar
  57. Briviba K, Roussyn I, Sharov VS, Sies H (1996) Attenuation of oxidation and nitration reactions of peroxynitrite by selenomethionine, selenocystine and ebselen. Biochem J 319:13–15PubMedGoogle Scholar
  58. Brozmanová J, Mániková D, Vlčková V, Chovanec M (2010) Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol 84:919–938PubMedCrossRefGoogle Scholar
  59. Bruning CA, Prigol M, Roehrs JA, Zeni G, Nogueira CW (2010) Evidence for the involvement of mu-opioid and delta-opioid receptors in the antinociceptive effect caused by oral administration of m-trifluoromethyl-diphenyl diselenide in mice. Behav Pharmacol 21:621–626PubMedCrossRefGoogle Scholar
  60. Brüning CA, Prigol M, Roehrs JA, Nogueira CW, Zeni G (2009) Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice. Behav Brain Res 205:511–517PubMedCrossRefGoogle Scholar
  61. Bubolz AH, Wu QP, Larsen BT, Gutterman DD, Liu YP (2007) Ebselen reduces nitration and restores voltage-gated potassium channel function in small coronary arteries of diabetic rats. Am J Physiol Heart Circ Physiol 293:H2231–H2237PubMedCrossRefGoogle Scholar
  62. Burger ME, Alves A, Callegari L, Athayde FR, Nogueira CW, Zeni G, Rocha JB (2003) Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum. Prog Neuropsychopharmacol Biol Psychiatry 27:135–140Google Scholar
  63. Burger M, Fachinetto R, Calegari L, Paixao MW, Braga AL, Rocha JBT (2004) Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide. Brain Res Bull 64:339–345PubMedCrossRefGoogle Scholar
  64. Burger ME, Fachinetto R, Zeni G, Rocha JBT (2005) Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain. Pharmacol Biochem Behav 81:608–615PubMedCrossRefGoogle Scholar
  65. Burger ME, Fachinetto R, Wagner C, Perottoni J, Pereira RP, Zeni G, Rocha JBT (2006) Effects of diphenyl-diselenide on orofacial dyskinesia model in rats. Brain Res Bull 70:165PubMedCrossRefGoogle Scholar
  66. Burk RF, Hill KE (1993) Regulation of selenoproteins. Ann Rev Nutr 13:65–81CrossRefGoogle Scholar
  67. Cahpman PM (1999) Selenium—a potential time bomb or just another contaminant Hum. Ecol Risk Assess 5:1123–1138Google Scholar
  68. Caldwell KA, Tappel AL (1965) Acceleration of sulfhydryl oxidations by selenocystine. Arch Biochem Biophys 112:196–200PubMedCrossRefGoogle Scholar
  69. Cao S, Durrani F, Rustum YM (2004) Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 10:2561–2569PubMedCrossRefGoogle Scholar
  70. Carlson BA, Yoo MH, Tsuji PA, Gladyshev VN, Hatfield DL (2009) Mouse models targeting selenocysteine trna. Expression for elucidating the role of selenoproteins in health and development. Molecules 14:3509–3527PubMedCrossRefGoogle Scholar
  71. Centurião FB, Dalla Corte CL, Paixão MW, Braga AL, Zeni G, Emanuelli T, Rocha JBT (2005) Effect of ebselen and organochalcogenides on excitotoxicity induced by glutamate in isolated chick retina. Brain Res 1039:146–152PubMedCrossRefGoogle Scholar
  72. Chaudière J, Courtin O, Leclaire J (1992) Glutathione oxidase activity of selenocystamine: a mechanistic study. Arch Biochem Biophys 296:328–336PubMedCrossRefGoogle Scholar
  73. Chen J, Berry MJ (2003) Selenium and selenoproteins in the brain and brain diseases. J Neurochem 86:1–12PubMedCrossRefGoogle Scholar
  74. Chen T, Wong YS (2009) Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. Int J Biochem Cell Biol 41:666–676PubMedCrossRefGoogle Scholar
  75. Chen GP, Ziegler DM (1994) Liver microsome and flavin-containing monooxygenase catalyzed oxidation of organic selenium-compounds. Arch Biochem Biophys 312:566–572PubMedCrossRefGoogle Scholar
  76. Chen JJ, Boylan LM, Wu CK, Spallholz JE (2007) Oxidation of glutathione and superoxide generation by inorganic and organic selenium compounds. Biofactors 31:55–66PubMedCrossRefGoogle Scholar
  77. Chen KM, Sacks PG, Spratt TE, Lin JM, Boyiri T, Schwartz J, Richie JP, Calcagnotto A, Das A, Bortner J, Zhao Z, Amin S, Guttenplan J, El-Bayoumy K (2009) Modulations of benzo[a]pyrene-induced DNA adduct, cyclin D1 and PCNA in oral tissue by 1, 4-phenylenebis(methylene)selenocyanate. Biochem Biophys Res Comm 383:151–155PubMedCrossRefGoogle Scholar
  78. Christison J, Sies H, Stocker R (1994) Human blood cells support the reduction of low-density-lipoprotein-associated cholesteryl ester hydroperoxides by albumin-bound ebselen. Biochem J 304:341–345PubMedGoogle Scholar
  79. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Kongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 276:1957–1963PubMedCrossRefGoogle Scholar
  80. Comasseto JV (2010) Selenium and tellurium chemistry: historical background. J Braz Chem Soc 21:2027–2031CrossRefGoogle Scholar
  81. Combs GF Jr (2001a) Considering the mechanisms of cancer prevention by selenium. Adv Exp Med Biol 492:107–117PubMedCrossRefGoogle Scholar
  82. Combs GF Jr (2001b) Impact of selenium and cancer-prevention findings on the nutrition-health paradigm. Nutr Cancer 40:6–11PubMedCrossRefGoogle Scholar
  83. Combs GF Jr, Gray WP (1998) Chemopreventive agents: selenium. Pharmacol Ther 79:179–192PubMedCrossRefGoogle Scholar
  84. Combs GF Jr, Clark LC, Turnbull BW (2001) An analysis of cancer prevention by selenium. Biofactors 14:153–159PubMedCrossRefGoogle Scholar
  85. Conaway CC, Upadhyaya P, Meschter CL, Kurtzke C, Marcus LA, El-Bayoumy K (1992) Subchronic toxicity of benzyl selenocyanate and 1, 4-phenylenebis(methylene)selenocyanate in F344 rats. Fundam Appl Toxicol 19:563–574PubMedCrossRefGoogle Scholar
  86. Cone JE, Del Río RM, Davis JN, Stadtman TC (1976) Chemical characterization of the selenoprotein component of clostridial glycine reductase: identification of selenocysteine as the organoselenium moiety. Proc Natl Acad Sci USA 73:2659–2663PubMedCrossRefGoogle Scholar
  87. Cooper AJL, Kristal BS (1997) Multiple roles of glutathione in the central nervous system. Biol Chem 378:793–802PubMedGoogle Scholar
  88. Costa CA, Trivelato GC, Pinto AM, Bechara EJ (1997) Correlation between plasma 5-aminolevulinic acid concentrations and indicators of oxidative stress in lead-exposed workers. Clin Chem 43:1196–1202PubMedGoogle Scholar
  89. Cotgreave IA, Sandy MS, Berggren M, Moldeus PM, Smith MT (1987) N-acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytes. Biochem Pharmacol 36:2899–2904PubMedCrossRefGoogle Scholar
  90. Cotgreave IA, Johansson U, Westergren G, Moldeus PW, Brattsand R (1988) The anti-inflammatory activity of ebselen but not thiols in experimental alveolitis and bronchiolitis. Agents Actions 24:313–319PubMedCrossRefGoogle Scholar
  91. Cotgreave IA, Duddy SK, Kass GEN, Thompson D, Moldeus P (1989) Studies on the anti-inflammatory activity of ebselen: Ebselen interferes with granulocyte oxidative burst by dual inhibition of nadph oxidase and protein kinase C. Biochem Pharmacol 38:649–656PubMedCrossRefGoogle Scholar
  92. Czeczot H, Scibior D, Skrzycki M, Podsiad M (2006) Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochim Pol 53:237–241PubMedGoogle Scholar
  93. da Rocha JT, Sperança A, Nogueira CW, Zeni G (2009) Hypolipidaemic activity of orally administered diphenyl diselenide in Triton WR-1339-induced hyperlipidaemia in mice. J Pharm Pharmacol 61:1673–1679PubMedCrossRefGoogle Scholar
  94. Dalla Corte CL, Fachinetto R, Puntel R, Wagner C, Nogueira CW, Soares FAA, Rocha JBT (2009) Chronic treatment with fluphenazine alters parameters of oxidative stress in liver and kidney of rats. Basic Clin Pharmacol Toxicol 105:51–57CrossRefGoogle Scholar
  95. Davis RL, Spallholz JE (1996) Inhibition of selenite-catalyzed superoxide generation and formation of elemental selenium (Se degrees) by copper, zinc, and aurintricarboxylic acid (ATA). Biochem Pharmacol 51:1015–1020PubMedCrossRefGoogle Scholar
  96. Davis CD, Feng Y, Hein DW, Finley JW (1999) The chemical form of selenium influences 3, 2′-dimethyl-4-aminobiphenyl-DNA adduct formation in rat colon. J Nutr 129:63–69PubMedGoogle Scholar
  97. Dawson DA, Masayasu H, Graham DI, Macrae IM (1995) The neuroprotective efficacy of ebselen (a glutathione-peroxidase mimic) on brain-damage induced by transient focal cerebral-ischemia in the rat. Neurosci Lett 185:65–69PubMedCrossRefGoogle Scholar
  98. de Bem AF, Portella RDL, Perottoni J, Becker E, Bohrer D, Paixao MW, Nogueira CW, Zeni G, Rocha JBT (2006) Changes in biochemical parameters in rabbits blood after oral exposure to diphenyl diselenide for long periods. Chem Biol Interact 162:1–10PubMedCrossRefGoogle Scholar
  99. de Bem AF, Portella RD, Farina M, Perottoni J, Paixao MW, Nogueira CW, Rocha JBT (2007) Low toxicity of diphenyl diselenide in rabbits: a long-term study. Basic Clin Pharmacol Toxicol 101:47–55PubMedCrossRefGoogle Scholar
  100. de Bem AF, Farina M, Portella RL, Nogueira CW, Dinis TC, Laranjinha JA, Almeida LM, Rocha JBT (2008) Diphenyl diselenide, a simple glutathione peroxidase mimetic, inhibits human LDL oxidation in vitro. Atherosclerosis 201:92–100PubMedCrossRefGoogle Scholar
  101. de Bem AF, Portella RD, Colpo E, Duarte MMMF, Frediane A, Taube PS, Nogueira CW, Farina M, da Silva EL, Rocha JBT (2009) Diphenyl diselenide decreases serum levels of total cholesterol and tissue oxidative stress in cholesterol-fed rabbits. Basic Clin Pharmacol Toxicol 105:17–23PubMedCrossRefGoogle Scholar
  102. de Koning AJ (2002) The antioxidant ethoxyquin and its analogues: a review. Int J Food Prop 5:451–461CrossRefGoogle Scholar
  103. De Silva V, Woznichak MM, Burns KL, Grant KB, May SW (2004) Selenium redox cycling in the protective effects of organoselenides against oxidant-induced DNA damage. J Am Chem Soc 126:2409–2413PubMedCrossRefGoogle Scholar
  104. Degrandi TH, Oliveira IM, d’Almeida GS, Garcia CRL, Villela IV, Guecheva TN, Rosa RM, Henriques JAP (2010) Evaluation of the cytotoxicity, genotoxicity and mutagenicity of diphenyl ditelluride in several biological models. Mutagenesis 25:257–269PubMedCrossRefGoogle Scholar
  105. Dhanarajan R, Abraham P, Isaac B (2006) Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats. Basic Clin Pharmacol Toxicol 99:267–272PubMedCrossRefGoogle Scholar
  106. Dhanasekaran M, Uthayathas S, Karuppagounder SS, Parameshwaran K, Suppiramaniam V, Ebadi M, Brown-Borg HM (2006) Ebselen effects on MPTP-induced neurotoxicity. Brain Res 1118:251–254PubMedCrossRefGoogle Scholar
  107. Dhingra S, Bansal MP (2006) Hypercholesterolemia and LDL receptor mRNA expression: modulation by selenium supplementation. Biometals 19:493–501PubMedCrossRefGoogle Scholar
  108. Dickson RC, Tappel AL (1969) Reduction of selenocystine by cysteine or glutathione. Arch Biochem Biophys 130:547–550PubMedCrossRefGoogle Scholar
  109. Donaldson MS (2004) Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3:1–21CrossRefGoogle Scholar
  110. dos Santos RA, Jordão Jrb AA, Vannucchi H, Takahashi CS (2007) Protection of doxorubicin-induced DNA damage by sodium selenite and selenomethionine in Wistar rats. Nutr Res 27:343–348CrossRefGoogle Scholar
  111. Drake EN (2006) Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med Hypotheses 67:318–322PubMedCrossRefGoogle Scholar
  112. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649–671PubMedCrossRefGoogle Scholar
  113. Drudge-Coates L (2009) SELECT shows no effect on prostate cancer prevention. Int J Urol Nurs 3:13–15CrossRefGoogle Scholar
  114. Dumont E, Vanhaecke F, Cornelis R (2006) Selenium speciation from food source to metabolites: a critical review. Anal Bioanal Chem 385:1304–1323PubMedCrossRefGoogle Scholar
  115. El-Bayoumy K (1985) Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. Cancer Res 45:3631–3635PubMedGoogle Scholar
  116. El-Bayoumy K (1991) The role of selenium in cancer prevention. In: Devita VT Jr, Hellmann S, Rosenberg SA (eds) Cancer prevention, 4th edn. JB Lippincott Company, Philadelphia, pp 1–15Google Scholar
  117. El-Bayoumy K (1994) Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials. Carcinogenesis 15:2395–2420PubMedCrossRefGoogle Scholar
  118. El-Bayoumy K (2001) The protective role of selenium on genetic damage and on cancer. Mutat Res 475:123–139PubMedCrossRefGoogle Scholar
  119. El-Bayoumy K, Sinha R (2004) Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 551:181–197PubMedCrossRefGoogle Scholar
  120. El-Bayoumy K, Upadhyaya P, Date V, Sohn OS, Fiala ES, Reddy B (1991) Selenium in the chemoprevention of carcinogenesis.10. Metabolism of [c-14] benzyl selenocyanate in the F344 rat. Chem Res Toxicol 4:560–565PubMedCrossRefGoogle Scholar
  121. El-Bayoumy K, Chae YH, Upadhyaya P, Meschter C, Cohen LA, Reddy BS (1992) Inhibition of 7, 12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague–Dawley rats by the synthetic organoselenium compound, 1, 4-phenylenebis(methylene)-selenocyanate. Cancer Res 52:2402–2407PubMedGoogle Scholar
  122. El-Bayoumy K, Upadhyaya P, Desai DH, Amin S, Hecht SS (1993) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1, 4-phenylenebis(methylene)selenocyanate. Carcinogenesis 14:1111–1113PubMedCrossRefGoogle Scholar
  123. El-Bayoumy K, Upadhyaya P, Chae YH, Sohn OS, Rao CV, Fiala E, Reddy BS (1995) Chemoprevention of cancer by organoselenium compounds. J Cell Biochem Suppl 22:92–100PubMedCrossRefGoogle Scholar
  124. El-Bayoumy K, Upadhyaya P, Desai DH, Amin S, Hoffmann D, Wynder EL (1996) Effects of 1, 4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res 16:2709–2712PubMedGoogle Scholar
  125. El-Bayoumy K, Chung FL, Richie J Jr, Reddy BS, Cohen L, Weisburger J, Wynder EL (1997) Dietary control of cancer. Proc Soc Exp Biol Med 216:211–223PubMedGoogle Scholar
  126. El-Bayoumy K, Rao CV, Reddy BS (2001) Multiorgan sensitivity to anticarcinogenesis by the organoselenium 1, 4-phenylenebis(methylene)selenocyanate. Nutr Cancer 40:18–27PubMedCrossRefGoogle Scholar
  127. El-Bayoumy K, Das A, Narayanan B, Narayanan N, Fiala ES, Desai D, Rao CV, Amin S, Sinha R (2006) Molecular targets of the chemopreventive agent 1, 4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer. Carcinogenesis 27:1369–1376PubMedCrossRefGoogle Scholar
  128. Emerit J, Edeas M, Bricaire F (2004) Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58:39–46PubMedCrossRefGoogle Scholar
  129. Engman L, Stern D, Cotgreave IA, Andersson CM (1992) Thiol peroxidase-activity of diaryl ditellurides as determined by a H-1-NMR Method. J Am Chem Soc 114:9737–9743CrossRefGoogle Scholar
  130. Engman L, Andersson C, Morgenstern R, Cotgreave IA, Andersson CM, Hallberg A (1994) Evidence for a common selenolate intermediate in the glutathione peroxidase-like catalysis of A-(phenylselenenyl) ketones and diphenyl diselenide. Tetrahedron 50:2929–2938CrossRefGoogle Scholar
  131. Engman L, Stern D, Frisell H, Vessman K, Berglund M, Ek B, Andersson CM (1995) Synthesis, antioxidant properties, biological activity and molecular modelling of a series of chalcogen analogues of the 5-lipoxygenase inhibitor DuP 654. Bioorg Med Chem 3:1255–1262PubMedCrossRefGoogle Scholar
  132. Engman L, Cotgreave I, Angulo M, Taylor CW, Paine-Murrieta GD, Powis G (1997) Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents. Anticancer Res 17:4599–4605PubMedGoogle Scholar
  133. Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Puntel RL, Paixão MW, Braga AL, Calixto JB, Rocha JBT, Ferreira J (2007) Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats. Psychopharmacology 194:423–432PubMedCrossRefGoogle Scholar
  134. Facompre ND, El-Bayoumy K, Sun YW, Pinto JT, Sinha R (2010) 1, 4-Phenyle nebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and akt signaling in human prostate cancer cells. Cancer Prev Res 3:975–984CrossRefGoogle Scholar
  135. Fakih MG, Pendyala L, Smith PF, Creaven PJ, Reid ME, Badmaev V, Azrak RG, Prey JD, Lawrence D, Rustum YM (2006) A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solidtumors. Clin Cancer Res 12:1237–1244PubMedCrossRefGoogle Scholar
  136. Fakih MG, Pendyala L, Brady W, Smith PF, Ross ME, Creaven PJ, Badmaev V, Prey JD, Rustum YM (2008) A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors. Cancer Chemother Pharmacol 62:499–508PubMedCrossRefGoogle Scholar
  137. Fang J, Zhong L, Zhao R, Holmgren A (2005) Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin. Toxicol Appl Pharmacol 207:S103–S109CrossRefGoogle Scholar
  138. Farina M, Folmer V, Bolzan RC, Andrade LH, Zeni G, Braga AL, Rocha JBT (2001) Selenoxides inhibit delta-aminolevulinic acid dehydratase. Tox Let 119:27–37CrossRefGoogle Scholar
  139. Farina M, Barbosa NBV, Nogueira CW, Folmer V, Zeni G, Andrade LH, Braga AL, Rocha JBT (2002) Reaction of diphenyl diselenide with hydrogen peroxide and inhibition of delta-aminolevulinate dehydratase from rat liver and cucumber leaves. Braz J Med Biol Res 35:623–631PubMedCrossRefGoogle Scholar
  140. Farina M, Brandao R, Lara FS, Soares FAA, Souza DO, Rocha JBT (2003a) Mechanisms of the inhibitory effects of selenium and mercury on the activity of delta-aminolevulinate dehydratase from mouse liver, kidney and brain. Toxicol Let 139:55–66CrossRefGoogle Scholar
  141. Farina M, Dahm KCS, Schwalm FD, Brusque AM, Frizzo ME, Zeni G, Souza DO, Rocha JBT (2003b) Methylmercury increases glutamate release from brain synaptosomes and glutamate uptake by cortical slices from suckling rat pups: modulatory effect of ebselen. Toxicol Sci 73:135–140PubMedCrossRefGoogle Scholar
  142. Farina M, Frizzo MES, Soares FA, Schwalm FD, Dietrich MO, Zeni G, Rocha JBT, Souza DO (2003c) Ebselen protects against methylmercury-induced inhibition of glutamate uptake by cortical slices from adult mice. Toxicol Lett 144:351–357PubMedCrossRefGoogle Scholar
  143. Farina M, Soares FA, Zeni G, Souza DO, Rocha JB (2004) Additive pro-oxidative effects of methylmercury and ebselen in liver from suckling rat pups. Toxicol Lett 146:227–235PubMedCrossRefGoogle Scholar
  144. Feng Y, Finley JW, Davis CD, Becker WK, Fretland AJ, Hein DW (1999) Dietary selenium reduces the formation of aberrant crypts in rats administered 3, 2′-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol 157:36–42PubMedCrossRefGoogle Scholar
  145. Fiala ES, Joseph C, Sohn OS, El-Bayoumy K, Reddy BS (1991) Mechanism of benzylselenocyanate inhibition of azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res 51:2826–2830PubMedGoogle Scholar
  146. Fiala ES, Sohn OS, Li H, El-Bayoumy K, Sodum RS (1997) Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate. Carcinogenesis 18:1809–1815PubMedCrossRefGoogle Scholar
  147. Fiala ES, Staretz ME, Pandya GA, El-Bayoumy K, Hamilton SR (1998) Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis 19:597–604PubMedCrossRefGoogle Scholar
  148. Filipovska A, Kelso GF, Brown SE, Beer SM, Smith RAJ, Murphy MP (2005) Synthesis and characterization of a triphenylphosphonium conjugated peroxidase mimetic. J Biol Chem 280:24113–24126PubMedCrossRefGoogle Scholar
  149. Fischer H, Dereu N (1987) Mechanism of the catalytic reduction of hydroperoxides by ebselen: a selenium-77 NMR study. Bull Soc Chim Belg 96:757–768CrossRefGoogle Scholar
  150. Flohe L, Gunzler WA, Schock HH (1973) Glutathione peroxidase: a selenoenzyme. FEBS Lett 32:132–134PubMedCrossRefGoogle Scholar
  151. Foiles PG, Miglietta L, Dolan LR, El-Bayoumy K, Ronai Z (1993) Modulation of carcinogen-induced polyoma dna-replication by organoselenium and organosulfur chemopreventive agents. Int J Oncol 2:413–418PubMedGoogle Scholar
  152. Foiles PG, Fujiki H, Suganuma M, Okabe S, Yatsunami J, Miglietta LM, Upadhyaya P, El-Bayoumy K, Ronai Z (1995) Inhibition of pkc and pka by chemopreventive organoselenium compounds. Int J Oncol 7:685–690PubMedGoogle Scholar
  153. Folmer V, Farina M, Maciel EN, Nogueira CW, Zeni G, Emanuelli T, Rocha JBT (2004) Methyl phenyl selenide causes heme biosynthesis impairment and its toxicity is not modified by dimethyl sulphoxide in vivo. Drug Chem Toxicol 27:331–340PubMedCrossRefGoogle Scholar
  154. Fordyce F (2007) Selenium geochemistry and health. Ambio 36:94–97PubMedCrossRefGoogle Scholar
  155. Forstrom JW, Zakowski JJ, Tappel AL (1978) Identification of the catalytic site of rat liver glutathione peroxidase as a selenocysteine. Biochemistry 17:2639–2644PubMedCrossRefGoogle Scholar
  156. Foster LH, Sumar S (1997) Selenium in health and disease: a review. Crit Rev Food Sci Nutr 37:211–228PubMedCrossRefGoogle Scholar
  157. Franke KW (1934a) A new toxicant occurring naturally in certain samples of plant foodstuffs: I. Results obtained in preliminary feeding trials. J Nutr 8:597–608Google Scholar
  158. Franke KW (1934b) A new toxicant occurring naturally in certain samples of plant foodstuffs: II. The occurrence of the toxicant in the protein fraction. J Nutr 8:609–613Google Scholar
  159. Franke KW, Painter EP (1935) Selenium in proteins from toxic foodstuffs: IV. The effect of feeding toxic proteins, toxic protein hydrolysates, and toxic protein hydrolysates from which the selenium has been removed. J Nutr 10:599–611Google Scholar
  160. Franke KW, Potter VR (1935) A new toxicant occurring naturally in certain samples of plant foodstuffs: IX. Toxic effects of orally ingested selenium. J Nutr 10:213–221Google Scholar
  161. Freitas AS, Prestes AS, Wagner C, Sudati JH, Alves D, Porciúncula LO, Kade IJ, Rocha JBT (2010) Reduction of diphenyl diselenide and analogs by mammalian thioredoxin reductase is independent of their gluthathione peroxidase-like activity: a possible novel pathway for their antioxidant activity. Molecules 15:7699–7714CrossRefGoogle Scholar
  162. Frost DV, Olson OE (1972) The two faces of selenium—can selenophobia be cured? CRC Crit Rev Toxicol 1:467–514PubMedCrossRefGoogle Scholar
  163. Fürstenau CR, Spier AP, Rücker B, Berti SL, Battastini AMO, Sarkis JJF (2004) The effect of ebselen on adenine nucleotide hydrolysis by platelets from adult rats. Chem Biol Interact 148:93–99PubMedCrossRefGoogle Scholar
  164. Gabryel B, Malecki A (2006) Ebselen attenuates oxidative stress in ischemic astrocytes depleted of glutathione. Comparison with glutathione precursors. Pharmacol Rep 58:381–392PubMedGoogle Scholar
  165. Galet V, Bernier JL, Hénichart JP, Lesieur D, Abadie C, Rochette L, Lindenbaum A, Chalas J, de la Faverie JFR, Pfeiffer B, Renard P (1994) Benzoselenazolinone derivatives designed to be glutathione peroxidase mimetics feature inhibition of cyclooxygenase/5-lipoxygenase pathways and anti-inflammatory activity. J Med Chem 37:2903–2911PubMedCrossRefGoogle Scholar
  166. Ganther HE (1968) Selenotrisulfides formation by reaction of thiols with selenious acid. Biochemistry 7:2898–2905PubMedCrossRefGoogle Scholar
  167. Ganther HE, Ip C (2001) Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. J Nutr 131:301–304PubMedGoogle Scholar
  168. Gasdaska JR, Berggren M, Powis G (1995) Cell-growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ 6:1643–1650PubMedGoogle Scholar
  169. Gealekman O, Brodsky SV, Zhang F, Chander PN, Friedli C, Nasjletti A, Goligorsky MS (2004) Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with ebselen. Kidney Int 66:2337–2347PubMedCrossRefGoogle Scholar
  170. Geiger PG, Lin F, Girotti AW (1993) Selenoperoxidase-mediated cytoprotection against the damaging effects of tert-butyl hydroperoxide on leukemia cells. Free Radic Bio Med 14:251–266CrossRefGoogle Scholar
  171. Ghisleni G, Porciúncula LO, Cimarosti H, Rocha JBT, Salbego CG, Souza DO (2003) Diphenyl diselenide protects rat hippocampal slices submitted to oxygen-glucose deprivation and diminishes inducible nitric oxide synthase immunocontent. Brain Res 986:196–199PubMedCrossRefGoogle Scholar
  172. Ghisleni G, Kazauckas V, Both FL, Pagnussat N, Mioranzza S, Rocha JBT, Souza DO, Porciúncula LO (2008a) Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAA and 5HT receptors. Prog Neuro-Psychopharmacol Biol Psychiatry 32:1508–1515CrossRefGoogle Scholar
  173. Ghisleni G, Porciúncula LO, Mioranzza S, Boeck CR, Rocha JBT, Souza DO (2008b) Selenium compounds counteract the stimulation of ecto-nucleotidase activities in rat cultured cerebellar granule cells: putative correlation with neuroprotective effects. Brain Res 1221:134–140PubMedCrossRefGoogle Scholar
  174. Ghose A, Fleming J, Harrison PR (2001) Selenium and signal transduction: roads to cell death and anti-tumour activity. Biofactors 14:127–133PubMedCrossRefGoogle Scholar
  175. Gill R, Tsung A, Billiar T (2010) Linking oxidative stress to inflammation: toll-like receptors. Free Rad Biol Med 48:1121–1132PubMedCrossRefGoogle Scholar
  176. Golombieski RM, Graichen DAS, da Rocha JBT, Valente VLD, Loreto ELD (2008a) Over-activation of the Drosophila melanogaster hsp83 gene by selenium intoxication. Gen Mol Biol 31:128–135CrossRefGoogle Scholar
  177. Golombieski RM, Graichen DAS, Pivetta LA, Nogueira CW, Loreto ELS, Rocha JBT (2008b) Diphenyl diselenide [(PhSe)(2)] inhibits Drosophila melanogaster delta-aminolevulinate dehydratase (delta-ALA-D) gene transcription and enzyme activity. Comp Biochem Physiol C-Tox Pharmacol 147:198–204Google Scholar
  178. Gopalakrishna R, Gundimeda U (2002) Methylselenol, the active metabolite of selenium, selectively inhibits protein kinase C in precancer cells at the promotional stage of carcinogenesis. J Nutr 132:3819S–3823SPubMedGoogle Scholar
  179. Gopalakrishna R, Chen ZH, Gundimeda U (1997) Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: its role in inhibition of tumor promotion. Arch Biochem Biophys 348:37–48PubMedCrossRefGoogle Scholar
  180. Goulet AC, Chigbrow M, Frisk P, Nelson MA (2005) Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells. Carcinogenesis 26:109–117PubMedCrossRefGoogle Scholar
  181. Griffiths HR, Dowling EJ, Sahinoglu T, Blake DR, Parnham M, Lunec J (1992) The selective protection afforded by ebselen against lipid peroxidation in an ROS-dependent model of inflammation. Agents Actions 36:107–111PubMedCrossRefGoogle Scholar
  182. Gross SS, Wolin MS (1995) Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57:737–769PubMedCrossRefGoogle Scholar
  183. Guerin PJ, Gauthier ER (2003) Induction of cellular necrosis by the glutathione peroxidase mimetic ebselen. J Cell Biochem 89:203–211PubMedCrossRefGoogle Scholar
  184. Gul S, Bahadir B, Hanci V, Acikgoz S, Bektas S, Ugurbas E, Ankarali H, Kalayci M, Acikgoz BJ (2010) Effects of ebselen versus nimodipine on cerebral vasospasm subsequent to experimental subarachnoid hemorrhage in rats. Clin Neurosci 17:608–611CrossRefGoogle Scholar
  185. Gustafson DL, Pritsos CA (1991) Inhibition of mitomyein-C aerobic toxicity by the seleno-organic antioxidant PZ-51. Cancer Chemoth Pharmacol 28:228–230CrossRefGoogle Scholar
  186. Haenen GRMM, de Rooij BM, Vermeulen NPE, Bast A (1990) Mechanism of the reaction of ebselen with endogenous thiols. Mol Pharmacol 37:412–422PubMedGoogle Scholar
  187. Hamacher J, Stammberger U, Weber E, Lucas R, Wendel A (2009) Ebselen improves ischemia-reperfusion injury after rat lung transplantation. Lung 187:98–103PubMedCrossRefGoogle Scholar
  188. Handa Y, Kaneko M, Takeuchi H, Tsuchida A, Kobayashi H, Kubota T (2000) Effect of an antioxidant, ebselen, on development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Surg Neurol 53:323–329PubMedCrossRefGoogle Scholar
  189. Hartung HP, Schafer B, Heininger K, Toyka KV (1986) Interference with arachidonic acid metabolism suppresses experimental allergic neuritis. Ann Neurol 20:168Google Scholar
  190. Hassan W, Ibrahim M, Deobald AM, Braga AL, Nogueira CW, Rocha JBT (2009a) pH-Dependent Fe(II) pathophysiology and protective effect of an organoselenium compound. FEBS Lett 583:1011–1016PubMedCrossRefGoogle Scholar
  191. Hassan W, Ibrahim M, Nogueira CW, Ahmed M, Rocha JBT (2009b) Effects of acidosis and Fe(II) on lipid peroxidation in phospholipid extract: comparative effect of diphenyl diselenide and ebselen. Environ Toxicol Pharmacol 28:152–154PubMedCrossRefGoogle Scholar
  192. Hassan W, Ibrahim M, Nogueira CW, Braga AL, Mohammadzai IU, Taube PS, Rocha JBT (2009c) Enhancement of iron-catalyzed lipid peroxidation by acidosis in brain homogenate: comparative effect of diphenyl diselenide and ebselen. Brain Res 1258:71–77PubMedCrossRefGoogle Scholar
  193. Hassan W, Ibrahim M, Rocha JBT (2009d) Low pH does not modulate antioxidant status of diphenyl ditelluride but exacerbates Fe(II)-induced lipid peroxidation in liver preparation. Drug Chem Toxicol 32:438–442PubMedCrossRefGoogle Scholar
  194. He M, Xing S, Yang B, Zhao L, Hua H, Liang Z, Zhou W, Zeng J, Pei Z (2007) Ebselen attenuates oxidative DNA damage and enhances its repair activity in the thalamus after focal cortical infarction in hypertensive rats. Brain Res 1181:83–92PubMedCrossRefGoogle Scholar
  195. Hermenegildo C, Nies E, Monsalve E, Puertas FJ, Higueras V, Romero FJ (1990) Some aspects of cardiac antioxidant defense: ebselen (PZ 51) treatment increases glutathione peroxidase activity in the rat heart. Biochem Soc Trans 18:1193–1194PubMedGoogle Scholar
  196. Holl V, Coelho D, Silbernagel L, Keyser JF, Waltzinger C, Dufour P, Bischoff PL (2000) Prevention of nitrogen mustard-induced apoptosis in normal and transformed lymphocytes by ebselen. Biochem Pharmacol 60:1565–1577PubMedCrossRefGoogle Scholar
  197. Holmgren A (1985) Thioredoxin. Annu Rev Biochem 54:237–271PubMedCrossRefGoogle Scholar
  198. Hort MA, Straliotto MR, Netto PM, da Rocha JB, Bem AF, Ribeiro-do-Valle RM (2011) Diphenyl diselenide effectively reduces atherosclerotic lesion in LDLr−/− mice by attenuation of oxidative stress and inflammation. J Cardiovasc Pharmacol [Epub ahead of print]Google Scholar
  199. Hu E, Kim JB, Sarraf P, Spiegelman BM (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274:2100–2103PubMedCrossRefGoogle Scholar
  200. Huang K, Liu H, Chen Z, Xu H (2002) Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis 162:137–144PubMedCrossRefGoogle Scholar
  201. Hunsaker DM, Spiller HA, Williams D (2005) Acute selenium poisoning: suicide by ingestion. J Forensic Sci 50:942–946PubMedCrossRefGoogle Scholar
  202. Ibrahim M, Prigol M, Hassan W, Nogueira CW, Rocha JBT (2010) Protective effect of binaphthyl diselenide, a synthetic organoselenium compound, on 2-nitropropane-induced hepatotoxicity in rats. Cell Biochem Funct 28:258–265PubMedCrossRefGoogle Scholar
  203. Ibrahim M, Luchese C, Pinton S, Roman SS, Hassan W, Nogueira CW, Rocha JBT (2011) Involvement of catalase in the protective effect of binaphthyl diselenide against renal damage induced by glycerol. Exp Toxicol Pathol 63:331–336PubMedCrossRefGoogle Scholar
  204. Ichikawa S, Omura K, Katayama T, Okamura N, Ohtsuka T, Ishibashi S, Masayasu H (1987) Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno-organic compound, ebselen. J Pharmacobiodyn 10:595–597PubMedGoogle Scholar
  205. Imai H, Masayasu H, Dewar D, Graham DI, Macrae IM (2001) Ebselen protects both gray model of focal and white matter in a rodent cerebral ischemia. Stroke 32:2149–2156PubMedCrossRefGoogle Scholar
  206. Ineu RP, Pereira ME, Aschner M, Nogueira CW, Zeni G, Rocha JBT (2008) Diphenyl diselenide reverses gastric lesions in rats: involvement of oxidative stress. Food Chem Toxicol 46:3023–3029PubMedCrossRefGoogle Scholar
  207. Ip C (1998) Lessons from basic research in selenium and cancer prevention. J Nutr 128:1845–1854PubMedGoogle Scholar
  208. Ip C, Ganther HE (1992) Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis 13:1167–1170PubMedCrossRefGoogle Scholar
  209. Ip C, El-Bayoumy K, Upadhyaya P, Ganther H, Vadhanavikit S, Thompson H (1994) Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention. Carcinogenesis 15:187–192PubMedCrossRefGoogle Scholar
  210. Issekutz AC, Lopes N (1992) Effect of Ebselen on polymorphonuclear leukocyte adhesion to and migration through cytokine-activated vascular endothelium. Int J Immunopharmacol 14:1383–1390PubMedCrossRefGoogle Scholar
  211. Iwaoka M, Tomoda S (1994) A model study on the effect of an amino group on the antioxidant activity of glutathione peroxidase. J Am Chem Soc 116:2557–2561CrossRefGoogle Scholar
  212. Jacobs M, Frost C (1981) Toxicological effects of sodium selenite in Sprague–Dawley rats. J Toxicol Environ Health 8:575–585PubMedCrossRefGoogle Scholar
  213. Jacquemin PV, Christiaens LE, Renson MJ (1992) Synthesis of 2H, 3-4-Dihydro-1, 2-benzoselenazin-3-one and derivatives : a new heterocyclic ring system. Tetrahedron Lett 33:3663–3866CrossRefGoogle Scholar
  214. Jacques-Silva MC, Nogueira CW, Broch LC, Flores EMM, Rocha JBT (2001) Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in liver and brain of mice. Pharmacol Toxicol 88:119–125PubMedCrossRefGoogle Scholar
  215. Janbaz KH, Gilani AH (2000) Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia 71:25–33PubMedCrossRefGoogle Scholar
  216. Jeong SW, Jung HJ, Rahman MM, Hwang JN, Seo YR (2009) Protective effects of selenomethionine against ionizing radiation under the modulation of p53 tumor suppressor. J Med Food 12:389–393PubMedCrossRefGoogle Scholar
  217. Jesse CR, Savegnago L, Nogueira CW (2007) Role of nitric oxide/cyclic GMP/K+ channel pathways in the antinociceptive effect caused by 2, 3-bis(mesitylseleno)propenol. Life Sci 81:1694–1702PubMedCrossRefGoogle Scholar
  218. Jesse CR, Savegnago L, Nogueira CW (2008) Spinal mechanisms of antinociceptive effect caused by oral administration of bis-selenide in mice. Brain Res 1231:25–33PubMedCrossRefGoogle Scholar
  219. Jesse CR, Rocha JBT, Nogueira CW, Savegnago L (2009) Further analysis of the antinociceptive action caused by p-methoxyl-diphenyl diselenide in mice. Pharmacol Biochem Behav 91:573–580PubMedCrossRefGoogle Scholar
  220. Jesse CR, Wilhelm EA, Bortolatto CF, Nogueira CW (2010a) Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice. Prog Neuro Psychopharmacol Biol Psychiatry 34:294–302CrossRefGoogle Scholar
  221. Jesse CR, Wilhelm EA, Bortolatto CF, Rocha JBT, Nogueira CW (2010b) Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test. Eur J Pharmacol 635:135–141PubMedCrossRefGoogle Scholar
  222. Jesse CR, Wilhelm EA, Nogueira CW (2010c) Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion. Psychopharmacology 212:513–522PubMedCrossRefGoogle Scholar
  223. Jiang C, Jiang WQ, Ip C, Ganther H, Lu LX (1999) Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinogen 26:213–225CrossRefGoogle Scholar
  224. Johnsen-Soriano S, Bosch-Morell F, Miranda M, Asensio S, Barcia JM, Roma J, Monfort P, Felipo V, Romero FJ (2007) Ebselen prevents chronic alcohol-induced rat hippocampal stress and functional impairment. Alcohol Clin Exp Res 31:486–492PubMedCrossRefGoogle Scholar
  225. Johnson WD, Morrissey RL, Kapetanovic I, Crowell JA, McCormick DL (2008) Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention. Food Chem Toxicol 46:1068–1078PubMedCrossRefGoogle Scholar
  226. Johshita H, Sasaki T, Matsui T, Hanamura T, Masayasu H, Asano T, Takakura K (1990) Effects of ebselen (PZ-51) on ischaemic brain oedema after focal ischaemia in cats. Acta Neurochir Suppl (Wien) 51:239–241Google Scholar
  227. Jozsef L, Filep JG (2003) Selenium-containing compounds attenuate peroxynitrite-mediated NF-kappaB and AP-1 activation and interleukin-8 gene and protein expression in human leukocytes. Free Radic Biol Med 35:1018–1027PubMedCrossRefGoogle Scholar
  228. Jung CH, Washburn MP, Wells WW (2002) Ebselen has dehydroascorbate reductase and thioltransferase-like activities. Biochem Biophys Res Commun 291:550–553PubMedCrossRefGoogle Scholar
  229. Jung HJ, Lee JH, Seo YR (2009) Enhancement of methyl methanesulfonate-induced base excision repair in the presence of selenomethionine on p53-dependent pathway. J Med Food 12:340–344PubMedCrossRefGoogle Scholar
  230. Kade IJ, Rocha JBT (2010) Comparative study on the influence of subcutaneous administration of diphenyl and dicholesteroyl diselenides on sulphydryl proteins and antioxidant parameters in mice. J Appl Toxicol 30:688–693PubMedCrossRefGoogle Scholar
  231. Kade IJ, Paixão MW, Rodrigues OE, Barbosa NB, Braga AL, Avila DS, Nogueira CW, Rocha JB (2008) Comparative studies on dicholesteroyl diselenide and diphenyl diselenide as antioxidant agents and their effect on the activities of Na+/K+ ATPase and delta-aminolevulinic acid dehydratase in the rat brain. Neurochem Res 33:167–178PubMedCrossRefGoogle Scholar
  232. Kade IJ, Borges VC, Savegnago L, Ibukun EO, Zeni G, Nogueira CW, Rocha JBT (2009a) Effect of oral administration of diphenyl diselenide on antioxidant status, and activity of delta aminolevulinic acid dehydratase and isoforms of lactate dehydrogenase, in streptozotocin-induced diabetic rats. Cell Biol Toxicol 25:415–424PubMedCrossRefGoogle Scholar
  233. Kade IJ, Nogueira CW, Rocha JBT (2009b) Diphenyl diselenide and streptozotocin did not alter cerebral glutamatergic and cholinergic systems but modulate antioxidant status and sodium pump in diabetic rats. Brain Res 1284:202–211PubMedCrossRefGoogle Scholar
  234. Kade IJ, Paixao MW, Rodrigues OED, Ibukun EO, Braga AL, Zeni G, Nogueira CW, Rocha JBT (2009c) Studies on the antioxidant effect and interaction of diphenyl diselenide and dicholesteroyl diselenide with hepatic delta-aminolevulinic acid dehydratase and isoforms of lactate dehydrogenase. Toxicol In Vitro 23:14–20PubMedCrossRefGoogle Scholar
  235. Kalai T, Mugesh G, Roy G, Sies H, Berente Z, Hideg K (2005) Combining benzo[d]isoselenazol-3-ones with sterically hindered alicyclic amines and nitroxides: enhanced activity as glutathione peroxidase mimics. Org Biomol Chem 3:3564–3569PubMedCrossRefGoogle Scholar
  236. Kalayci M, Coskun O, Cagavi F, Kanter M, Armutcu F, Gul S, Acikgoz B (2005) Neuroprotective effects of ebselen on experimental spinal cord injury in rats. Neurochem Res 30:403–410PubMedCrossRefGoogle Scholar
  237. Kamble P, Mohsin N, Jha A, Date A, Upadhaya A, Mohammad E, Khalil M, Pakkyara A, Budruddin M (2009) Selenium intoxication with selenite broth resulting in acute renal failure and severe gastritis. Saudi J Kidney Dis Transpl 20:106–111PubMedGoogle Scholar
  238. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet RA, Doody LA, Malone WF, Hawk ET, Sigman CC (1996) New agents for cancer chemoprevention. J Cell Biochem Suppl 26:1–28PubMedGoogle Scholar
  239. Khalil AM, Maslat AO (1990) Chromosome-aberrations, sister-chromatid exchanges and cell-cycle kinetics in human peripheral-blood lymphocytes exposed to organoselenium invitro. Mutat Res 232:227–232PubMedCrossRefGoogle Scholar
  240. Kiersztan A, Baranska A, Hapka M, Lebiedzinska M, Winiarska K, Dudziak M, Bryla J (2009) Differential action of methylselenocysteine in control and alloxan-diabetic rabbits. Chem Biol Interact 177:161–171PubMedCrossRefGoogle Scholar
  241. Kim EH, Sohn S, Kwon HJ, Kim SU, Kim MJ, Lee SJ, Choi KS (2007) Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Can Res 67:6314–6324CrossRefGoogle Scholar
  242. Kitahara J, Seko Y, Imura N (1993) Possible involvement of active oxygen species in selenite toxicity in isolated rat hepatocytes. Arch Toxicol 67:497–501PubMedCrossRefGoogle Scholar
  243. Knollema S, Elting JW, Dijkhuizen RM, Nicolay K, Korf J, Ter Horst GJ (1996) Ebselen (PZ-51) protects the caudate putamen against hypoxia/ischemia induced neuronal damage. Neurosci Res Commun 19:47–56CrossRefGoogle Scholar
  244. Kondoh S, Nagasawa S, Kawanishi M, Yamaguchi K, Kajimoto S, Ohta T (1999) Effects of ebselen on cerebral ischemia and reperfusion evaluated by microdialysis. Neurol Res 21:682–686PubMedGoogle Scholar
  245. Kono H, Arteel GE, Rusyn I, Sies H, Thurman RG (2001) Ebselen prevents early alcohol-induced liver injury in rats. Free Radic Biol Med 30:403–411PubMedCrossRefGoogle Scholar
  246. Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B (2000) Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen-Role of reactive oxygen and nitrogen species. J Biol Chem 275:33585–33592PubMedCrossRefGoogle Scholar
  247. Koyanagi T, Nakamuta M, Enjoji M, Iwamoto H, Motomura K, Sakai H, Nawata H (2001) The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats. Int J Mol Med 7:321–327PubMedGoogle Scholar
  248. Krasilinikov MA (2000) Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry (Mosc) 65:59–67Google Scholar
  249. Krause RJ, Glocke SC, Sicuri AR, Ripp SL, Elfarra AA (2006) Oxidative metabolism of seleno-l-methionine to l-methionine selenoxide by flavin-containing monooxygenases. Chem Res Toxicol 19:1643–1649PubMedCrossRefGoogle Scholar
  250. Kuhl P, Borbe HO, Discher H, Romer A, Safayhi H (1986) Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S, 12R–6-trans-isomer. Prostaglandins 31:1029–1048PubMedCrossRefGoogle Scholar
  251. Kumakura F, Mishra B, Priyadarsini KI, Iwaoka M (2010) A water-soluble cyclic selenide with enhanced glutathione peroxidase-like catalytic activities. Eur J Org Chem 3:440–445CrossRefGoogle Scholar
  252. Kumar S, Björnstedt M, Holmgren A (1992) Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur J Biochem 207:435–439PubMedCrossRefGoogle Scholar
  253. Kumar S, Singh HB, Wolmershauser G (2006) Protection against peroxynitrite-mediated nitration reaction by intramolecularly coordinated diorganoselenides. Organometallics 25:382–393CrossRefGoogle Scholar
  254. Kumar S, Engman L, Valgimigli L, Amorati R, Fumo MG, Pedulli GF (2007) Antioxidant profile of ethoxyquin and some of its S, Se, and Te analogues. J Org Chem 72:6046–6055PubMedCrossRefGoogle Scholar
  255. Kunwar A, Mishra B, Barik A, Kumbhare LB, Pandey R, Jain VK, Priyadarsini KI (2007) 3, 3′-Diselenodipropionic acid, an efficient peroxyl radical scavenger and a GPx mimic, protects erythrocytes (RBCs) from AAPH-induced hemolysis. Chem Res Toxicol 20:1482–1487PubMedCrossRefGoogle Scholar
  256. Kurebayashi Y, Tabuchi Y, Akasaki M (1989) Gastric cyto- protection by ebselen against the injury induced by neerotizing agents in rats. Drug Res 39:250–253Google Scholar
  257. Kyung-Min S, Liulan S, Seung JP, Jin-Hyun J, Kyung-Tae L (2009) Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kB inactivation. J Pharm Pharmacol 61:479–486Google Scholar
  258. Lapchak PA, Zivin JA (2003) Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits-synergism with low-dose tissue plasminogen activator. Stroke 34:2013–2018PubMedCrossRefGoogle Scholar
  259. Laurent TC, Moore EC, Reichard P (1964) Enzymatic synthesis of deoxyribonucleotides.4. isolation + characterization of thioredoxin hydrogen donor from escherichia coli B. J Biol Chem 239:3436–3444PubMedGoogle Scholar
  260. Lech T (2002) Suicide by sodium tetraoxoselenate(VI) poisoning. Forensic Sci Int 130:44–48PubMedCrossRefGoogle Scholar
  261. Lee O, Moon J, Chung Y (2003) The relationship between serum selenium levels and lipid profiles in adult women. J Nutr Sci Vitaminol (Tokyo) 49:397–404CrossRefGoogle Scholar
  262. Lee YJ, Choi B, Lee EH, Choi KS, Sohn S (2006) Immobilization stress induces cell death through production of reactive oxygen species in the mouse cerebral cortex. Neurosci Lett 392:27–31PubMedCrossRefGoogle Scholar
  263. Lemly DA (1999) Selenium impacts on fish: an insidious time bomb. Hum Ecol Risk Assess 5:1139–1151Google Scholar
  264. Letavayova L, Vlasakova D, Spallholz JE, Bromanova J, Chovanec M (2008) Toxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiae. Mutat Res 638:1–10PubMedCrossRefGoogle Scholar
  265. Leurs R, Timmerman H, Bast A (1989) Inhibition of superoxide anion radical production by ebselen (PZ 51) and its sulfur analogue (PZ. 25) in guinea pig alveolar macrophages. Biochem Int 18:295–299PubMedGoogle Scholar
  266. Leyck S, Parnham MJ (1990) Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen. Agents Actions 30:426–431PubMedCrossRefGoogle Scholar
  267. Li QJ, Bessems JG, Commandeur JN, Adams B, Vermeulen NP (1994) Mechanism of protection of ebselen against paracetamol- induced toxicity in rat hepatocytes. Biochem Pharmacol 48:1631–1640PubMedCrossRefGoogle Scholar
  268. Li J, Chen JJ, Zhang F, Zhang C (2000) Ebselen protection against hydrogen peroxide-induced cytotoxicity and DNA damage in HL-60 cells. Acta Pharmacol Sin 21:455–459PubMedGoogle Scholar
  269. Liu J, Luo G, Shen J (2007a) Progress in selenoenzyme mimics. Progr Chem 19:1928–1938Google Scholar
  270. Liu X, Guan WC, Ke W (2007b) C-60-based ebselen derivative: Synthesis by Bingel cyclopropanation and enhanced antioxidative and neuroprotective activity. J Braz Chem Soc 18:1322–1328CrossRefGoogle Scholar
  271. Lobanov AV, Fomenko DE, Zhang Y, Sengupta A, Hatfield DL, Gladyshev VN (2007) Evolutionary dynamics of eukaryotic selenoproteomes: large selenoproteomes may associate with aquatic life and small with terrestrial life. Gen Biol 8:R198CrossRefGoogle Scholar
  272. Lobanov AV, Hatfield DL, Gladyshev VN (2009) Eukaryotic selenoproteins and selenoproteomes. Biochem Biophys Acta (general subjects) 1790:1424–1428CrossRefGoogle Scholar
  273. Lu J, Holmgren A (2009) Selenoproteins. J Biol Chem 284:723–730PubMedCrossRefGoogle Scholar
  274. Lu J, Jiang C, Kaeck M, Ganther H, Vadhanavikit S, Ip C, Thompson H (1995) Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol 50:213–219PubMedCrossRefGoogle Scholar
  275. Lu J, Berndt C, Holmgren A (2009) Metabolism of selenium compounds catalyzed by the mammalian selenoprotein thioredoxin reductase. Biochim Biophys Acta 1790:1513–1519PubMedGoogle Scholar
  276. Luchese C, Nogueira CW (2010) Diphenyl diselenide in its selenol form has dehydroascorbate reductase and glutathione S-transferase-like activity dependent on the glutathione content. J Pharm Pharmacol 62:1146–1151PubMedCrossRefGoogle Scholar
  277. Luchese C, Stangherlin EC, Ardais AP, Nogueira CW, Santos FW (2007) Diphenyl diselenide prevents oxidative damage induced by cigarette smoke exposure in lung of rat pups. Toxicology 230:189–196PubMedCrossRefGoogle Scholar
  278. Luchese C, Pinton S, Nogueira CW (2009a) Brain and lungs of rats are differently affected by cigarette smoke exposure: antioxidant effect of an organoselenium compound. Pharmacol Res 59:194–201PubMedCrossRefGoogle Scholar
  279. Luchese C, Stangherlin EC, Gay BM, Nogueira CW (2009b) Antioxidant effect of diphenyl diselenide on oxidative damage induced by smoke in rats: involvement of glutathione. Ecotoxicol Environ Safety 72:248–254PubMedCrossRefGoogle Scholar
  280. Lugokenski TH, Müller LG, Taube PS, Rocha JB, Pereira ME (2011) Inhibitory effect of ebselen on lactate dehydrogenase activity from mammals: a comparative study with diphenyl diselenide and diphenyl ditelluride. Drug Chem Toxicol 34:66–76PubMedCrossRefGoogle Scholar
  281. Luo GM, Ren XJ, Liu JQ, Mu Y, Shen JC (2003) Towards more efficient glutathione peroxidase mimics: substrate recognition and catalytic group assembly. Curr Med Chem 10:1151–1183PubMedCrossRefGoogle Scholar
  282. Lynch ED, Gu RD, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hearing Res 201:81–89CrossRefGoogle Scholar
  283. Machado MS, Rosa RM, Dantas AS, Reolon GK, Appelt HR, Braga AL, Henriques JAN, Roesler R (2006) An organic selenium compound attenuates apomorphine-induced stereotypy in mice. Neurosci Lett 410:198–202PubMedCrossRefGoogle Scholar
  284. Machado MS, Villela IV, Moura DJ, Rosa RM, Salvador M, Lopes NP, Braga AL, Roesler R, Saffi J, Henriques JAP (2009) 3, 3-Ditrifluoromethyldiphenyl diselenide: A new organoselenium compound with interesting antigenotoxic and antimutagenic activities. Mutat Res 673:133–140Google Scholar
  285. Maciel EN, Bolzan RC, Braga AL, Rocha JBT (2000) Diphenyl diselenide and diphenyl ditelluride differentially affect delta-aminolevulinate dehydratase from liver, kidney, and brain of mice. J Biochem Mol Toxicol 14:310–319PubMedCrossRefGoogle Scholar
  286. Maciel EN, Flores EMM, Rocha JBT, Folmer V (2003) Comparative deposition of diphenyl diselenide in liver, kidney, and brain of mice. Bull Environ Contam Toxicol 70:470–476Google Scholar
  287. Maiorino M, Roveri A, Coassin M, Ursini F (1988) Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Biochem Pharmacol 37:2267–2271PubMedCrossRefGoogle Scholar
  288. Martinez-Ramos F, Salgado-Zamora H, Campos-Aldrete MH, Melendez-Camargo E, Marquez-Flores Y, Soriano-Garcia M (2008) Synthesis and anti-inflammatory activity evaluation of unsymmetrical selenides. Eur J Med Chem 43:1432–1437PubMedCrossRefGoogle Scholar
  289. Maslat AO, Khalil AM (1991) Mutagenic effects of 2 suspected anticarcinogenic organoselenium compounds in salmonella-typhimurium. Toxicol Environ Chem 33:23–29CrossRefGoogle Scholar
  290. Masumoto H, Sies H (1996) The reaction of ebselen with peroxynitrite. Chem Res Toxicol 9:262–267PubMedCrossRefGoogle Scholar
  291. Masumoto K, Kissner R, Koppenol WH, Sies H (1996) Kinetic study of the reaction of ebselen with peroxynitrite. FEBS Lett 398:179–182PubMedCrossRefGoogle Scholar
  292. Maulik N, Yoshida T (2000) Oxidative stress developed during open heart surgery induces apoptosis: reduction of apoptotic cell death by ebselen, a glutathione peroxidase mimic. J Cardiovasc Pharmacol 36:601–608PubMedCrossRefGoogle Scholar
  293. May JM, Mendiratta S, Hill KE, Burk RF (1997) Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J Biol Chem 272:22607–22610PubMedCrossRefGoogle Scholar
  294. Mazzanti CM, Spanevello R, Ahmed M, Pereira LB, Goncalves JF, Correa M, Schmatz R, Stefanello N, Leal DBR, Mazzanti A, Ramos AT, Martins TB, Danesi CC, Graca DL, Morsch VM, Schetinger MRC (2009) Pre-treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents. Int J Dev Neurosci 27:73–80PubMedCrossRefGoogle Scholar
  295. Meotti FC, Borges VC, Zeni G, Rocha JBT, Nogueira CW (2003) Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and Ebselen for rats and mice. Toxicol Lett 143:9–16PubMedCrossRefGoogle Scholar
  296. Meotti FC, Stangherlin EC, Zeni G, Nogueira CW, Rocha JBT (2004) Protective role of aryl and alkyl diselenides on lipid peroxidation. Environ Res 94:276–282PubMedCrossRefGoogle Scholar
  297. Meotti FC, Borges VC, Perottoni J, Nogueira CW (2008) Toxicological evaluation of subchronic exposure to diphenyl diselenide in rats. J Appl Toxicol 28:638–644Google Scholar
  298. Meotti FC, Coelho IS, Franco JL, Dafre AL, Rocha JBT, Santos ARS (2009) Redox modulation at the peripheral site alters nociceptive transmission in vivo. Clin Exp Pharmacol Physiol 36:272–277PubMedCrossRefGoogle Scholar
  299. Micke O, Schomburg L, Buentzel J, Kisters K, Muecke R (2009) Selenium in oncology: from chemistry to clinics. Molecules 14:3975–3988Google Scholar
  300. Miorelli ST, Rosa RM, Moura DJ, Rocha JC, Lobo LAC, Henriques JAP, Saffi J (2008) Antioxidant and anti-mutagenic effects of ebselen in yeast and in cultured mammalian V79 cells. Mutagenesis 23:93–99PubMedCrossRefGoogle Scholar
  301. Mishra B, Priyadarsini KI, Mohana H, Mugesh G (2006) Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds. Bioorg Med Chem Lett 16:5334–5338PubMedCrossRefGoogle Scholar
  302. Miyazawa T, Suzuki T, Fujimoto K, Kinoshita M (1993) Elimination of plasma phosphatidylcholine hydroperoxide by a seleno-organic compound, ebselen. J Biochem 114:588–591PubMedGoogle Scholar
  303. Montoya RG, Wargovich MJ (1997) Chemoprevention of gastrointestinal cancer. Cancer Metastasis Rev 16:405–419PubMedCrossRefGoogle Scholar
  304. Moretto MB, Funchal C, Zeni G, Rocha JBT, Pessoa-Pureur R (2005) Organoselenium compounds prevent hyperphosphorylation of cytoskeletal proteins induced by the neurotoxic agent diphenyl ditelluride in cerebral cortex of young rats. Toxicology 210:213–222PubMedCrossRefGoogle Scholar
  305. Morin D, Zini R, Ligeret H, Neckameyer W, Labidalle S, Tillement JP (2003) Dual effect of ebselen on mitochondrial permeability transition. Biocheml Pharmacol 65:1643–1651CrossRefGoogle Scholar
  306. Moussaoui S, Obinu MC, Daniel N, Reibaud M, Blanchard V, Imperato A (2000) The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson’s disease. Exp Neurol 166:235–245PubMedCrossRefGoogle Scholar
  307. Moxon AL, Rhian M (1943) Selenium poisoning. Physiol Rev 23:305–337Google Scholar
  308. Mugesh G, Panda A, Singh HB, Punekar NS, Butcher RJ (2001) Glutathione peroxidase-like antioxidant activity of diaryl diselenides: a mechanistic study. J Am Chem Soc 123:839–850PubMedCrossRefGoogle Scholar
  309. Mugesh G, du Mont WW, Wismach C, Jones PG (2002) Biomimetic studies on iodothyronine deiodinase intermediates: modeling the reduction of selenenyl iodide by thiols. Chembiochem 3:440–447PubMedCrossRefGoogle Scholar
  310. Mugesh G, Klotz LO, du Mont WW, Becker K, Sies H (2003) Selenenyl iodide: a new substrate for mammalian thioredoxin reductase. Org Biomol Chem 1:848–2852CrossRefGoogle Scholar
  311. Muller AS, Most E, Pallauf J (2005) Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice. J Anim Physiol Anim Nutr 89:94–104CrossRefGoogle Scholar
  312. Müller A, Cadenas E, Graf P, Sies H (1984) A novel biologically active seleno-organic compound I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochem Pharmacol 33:3235–3239PubMedCrossRefGoogle Scholar
  313. Müller A, Gabriel H, Sies H (1985) A novel biologically active selenoorganic compound—IV: protective glutathione-dependent effect of PZ 51 (Ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes. Biochem Pharmacol 34:1185–1189PubMedCrossRefGoogle Scholar
  314. Narayanan BA, Narayanan NK, Desai D, Pittman B, Reddy BS (2004) Effects of a combination of docosahexaenoic acid and 1, 4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells. Carcinogenesis 25:2443–2449PubMedCrossRefGoogle Scholar
  315. Nassir F, Moundras C, Bayle D, Serougne C, Gueux E, Rock E, Rayssiguier Y, Mazur A (1997) Effect of selenium deficiency on hepatic lipid and lipoprotein metabolism in the rat. Br J Nutr 78:493–500PubMedCrossRefGoogle Scholar
  316. Navarro-Alarcon M, Cabrera-Vique C (2008) Selenium in food and the human body: a review. Sci Total Environ 400:115–141PubMedCrossRefGoogle Scholar
  317. Navarro-Alarcon M, López-Martínez MC (2000) Essentiality of selenium in the human body: relationship with different diseases. Sci Total Environ 249:347–371PubMedCrossRefGoogle Scholar
  318. Nayini J, El-Bayoumy K, Sugie S, Cohen LA, Reddy BS (1989) Chemoprevention of experimental mammary carcinogenesis by the synthetic organoselenium compound, benzylselenocyanate, in rats. Carcinogenesis 10:509–512PubMedCrossRefGoogle Scholar
  319. Nelson AA, Fitzhugh OG, Calvery HO (1943) Liver tumors following cirrhosis caused by selenium in rats. Cancer Res 3:230–236Google Scholar
  320. Nishina A, Sekiguchi A, He Y, Koketsu M, Furukawa S (2008) Ebselen, a redox regulator containing a selenium atom, induces neurofilament m expression in cultured rat pheochromocytoma PC12 cells via activation of mitogen-activated protein kinase. J Neurosci Res 86:720–725PubMedCrossRefGoogle Scholar
  321. Nogueira CW, Rocha JBT (2010) Diphenyl diselenide: a Janus faced compound. J Braz Chem Soc 21:2055–2071CrossRefGoogle Scholar
  322. Nogueira CW, Rotta LN, Zeni G, Souza DO, Rocha JBT (2002) Exposure to Ebselen changes glutamate uptake and release by rat brain synaptosomes. Neurochem Res 27:283–288PubMedCrossRefGoogle Scholar
  323. Nogueira CW, Quinhones EB, Jung EAC, Zeni G, Rocha JBT (2003) Anti-inflammatory and antinociceptive activity of diphenyl diselenide. Inflamm Res 52:56–63PubMedCrossRefGoogle Scholar
  324. Nogueira CW, Zeni G, Rocha JBT (2004) Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 104:6255–6285PubMedCrossRefGoogle Scholar
  325. Nogueira CW, Borges LP, Souza ACG (2009) Oral administration of diphenyl diselenide potentiates hepatotoxicity induced by carbon tetrachloride in rats. J Appl Toxicol 29:156–164PubMedCrossRefGoogle Scholar
  326. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, Brodsky S, Goligorsky MS (2001) Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281:F948–F957PubMedGoogle Scholar
  327. Nowak P, Saluk-Juszczak J, Olas B, Kolodziejczyk J, Wachowicz B (2006) The protective effects of selenoorganic compounds against peroxynitrite-induced changes in plasma proteins and lipids. Cell Mol Biol Lett 11:1–11PubMedCrossRefGoogle Scholar
  328. Nozawa R, Arai M, Kuruto R, Motohashi T, Masayasu H (1996) Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen. J Pharm Pharmacol 48:64–67PubMedCrossRefGoogle Scholar
  329. Ogawa A, Yoshimoto T, Kikuchi H, Sano K, Saito I, Yamaguchi T, Yasuhara H (1999) Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial. Cerebrovasc Dis 9:112–118PubMedCrossRefGoogle Scholar
  330. Ogunmoyole T, Rocha JBT, Okoronkwo AE, Kade IJ (2009) Altered pH homeostasis modulates the glutathione peroxidase mimics and other antioxidant properties of diphenyl diselenide. Chem Biol Interact 182:106–111PubMedCrossRefGoogle Scholar
  331. Oh SH, Ganther HE, Hoekstra WG (1974) Selenium as a component of glutathione peroxidase isolated from ovine erythrocytes. Biochemistry 13:1825–1829Google Scholar
  332. Ohta Y, Kobayashi T, Inui K, Yoshino J, Nakazawa S (2002) Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Jpn J Pharmacol 90:295–303PubMedCrossRefGoogle Scholar
  333. Oldfield JE (1987) The two faces of selenium. J Nutr 177:2002–2008Google Scholar
  334. Oshita M, Takei Y, Kawano S, Fusamoto H, Kamada T (1994) Protective effect of ebselen on constrictive hepatic vasculature: prevention of alcohol-induced effects on portal pressure in perfused livers. J Pharmacol Exp Ther 271:20–24PubMedGoogle Scholar
  335. Ostrovidov S, Franck P, Joseph D, Martarello L, Kirsch G, Belleville F, Nabet P, Dousset B (2000) Screening of new antioxidant molecules using flow cytometry. J Med Chem 43:1762–1769PubMedCrossRefGoogle Scholar
  336. Oteiza PI, Bechara EJ (1993) 5-aminolevulinic acid induces lipid peroxidation in cardiolipin-rich liposomes. Arch Biochem Biophys 305:282–287PubMedCrossRefGoogle Scholar
  337. Ozaki M, Nakamura M, Teraoka S, Ota K (1997) Ebselen, a novel anti-oxidant compound, protects the rat liver from ischemia-reperfusion injury. Transpl Int 10:96–102PubMedCrossRefGoogle Scholar
  338. Painter EP (1941) The chemistry and toxicity of selenium compounds, with special reference to the selenium problem. Chem Rev 28:179–213CrossRefGoogle Scholar
  339. Parnham MJ, Kindt S (1984) A novel biologically-active organoselenium compound 3. Effects of PZ-51 (ebselen) on glutathione-peroxidase and secretory activities of mouse macrophages. Biochem Pharmacol 33:3247–3250PubMedCrossRefGoogle Scholar
  340. Parnham M, Sies H (2000) Ebselen: prospective therapy for cerebral ischaemia. Exp Op Inv Drugs 9:607–619CrossRefGoogle Scholar
  341. Patrick RA, Peters PA, Issekutz AC (1993) Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils. Agents Actions 40:186–190PubMedCrossRefGoogle Scholar
  342. Pawlas N, Malecki A (2007) Effects of ebselen on glutathione level in neurons exposed to arachidonic acid and 4-hydroxynonenal during simulated ischemia in vitro. Pharmacol Rep 59:708–714PubMedGoogle Scholar
  343. Pearson JK, Boyd RJ (2008) Effect of substituents on the GPx-like activity of ebselen: steric versus electronic. J Phys Chem A 112:1013–1017PubMedCrossRefGoogle Scholar
  344. Penatti CA, Bechara EJ, Demasi M (1996) delta-Aminolevulinic acid-induced synaptosomal Ca2+ uptake and mitochondrial permeabilization. Arch Biochem Biophys 335:53–60PubMedCrossRefGoogle Scholar
  345. Pereira B, Curi R, Kokubun E, Bechara EJ (1992) 5-Aminolevulinic acid-induced alterations of oxidative metabolism in sedentary and exercise-trained rats. J Appl Physiol 72:226–230PubMedGoogle Scholar
  346. Pinsent J (1954) The need for selenite and molybdate in the formation of formic dehydrogenase by members of the coli-aerogenes group of bacteria. Biochem J 57:10–16PubMedGoogle Scholar
  347. Pinto JT, Sinha R, Papp K, Facompre ND, Desai D, El-Bayoumy K (2007) Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. Int J Cancer 120:1410–1417PubMedCrossRefGoogle Scholar
  348. Pinto LG, Jesse CR, Nogueira CW, Savegnago L (2008) Evidence for the involvement of glutamatergic and GABAergic systems and protein kinase A pathway in the antinociceptive effect caused by p-methoxy-diphenyl diselenide in mice. Pharmacol Biochem Behav 88:487–496PubMedCrossRefGoogle Scholar
  349. Pinton S, da Rocha JT, Zeni G, Nogueira CW (2010) Organoselenium improves memory decline in mice: involvement of acetylcholinesterase activity. Neurosci Lett 472:56–60PubMedCrossRefGoogle Scholar
  350. Pivetta LA, Pereira RP, Farinon M, de Bem AF, Perottoni J, Soares JC, Duarte MFM, Zeni G, Rocha JBT, Farina M (2006) Ethanol inhibits δ-aminolevulinate dehydratase and glutathione peroxidase activities in mice liver: protective effects of ebselen and N-acetylcysteine. Environ Toxicol Pharmacol 21:338–343PubMedCrossRefGoogle Scholar
  351. Plano D, Baquedano Y, Ibanez E, Jimenez I, Palop JA, Spallholz JE, Sanmartin C (2010) Antioxidant-prooxidant properties of a new organoselenium compound. Molecules 15:7292–7312PubMedCrossRefGoogle Scholar
  352. Porciúncula LO, Rocha JBT, Boeck CR, Vendite D, Souza DO (2001) Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons. Neurosci Lett 299:217–220PubMedCrossRefGoogle Scholar
  353. Porciúncula LO, Rocha JBT, Cimarosti H, Vinade L, Ghisleni G, Salbego CG, Souza DO (2003) Neuroprotective effect of ebselen on rat hippocampal slices submitted to oxygen-glucose deprivation: correlation with immunocontent of inducible nitric oxide synthase. Neurosci Lett 346:101–104PubMedCrossRefGoogle Scholar
  354. Porciúncula LO, Rocha JBT, Ghisleni G, Tavares RG, Souza DO (2004) The effects of ebselen on [3H]glutamate uptake by synaptic vesicles from rat brain. Brain Res 1027:192–195PubMedCrossRefGoogle Scholar
  355. Posser T, Moretto MB, Dafre AL, Farina M, Rocha JBT, Nogueira CW, Zeni G, Ferreira JS, Leal RB, Franco JL (2006) Antioxidant effect of diphenyl diselenide against sodium nitroprusside (SNP) induced lipid peroxidation in human platelets and erythrocyte membranes: an in vitro evaluation. Chem Biol Interact 164:126–135PubMedCrossRefGoogle Scholar
  356. Posser T, Franco JL, dos Santos DA, Rigon AP, Farina M, Dafré AL, Rocha JBT, Leal RB (2008) Diphenyl diselenide confers neuroprotection against hydrogen peroxide toxicity in hippocampal slices. Brain Res 1199:138–147PubMedCrossRefGoogle Scholar
  357. Posser T, Kaster MP, Baraúna SC, Rocha JBT, Rodrigues ALS, Leal RB (2009) Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system. Eur J Pharmacol 602:85–91PubMedCrossRefGoogle Scholar
  358. Posser T, de Paula MT, Franco JL, Leal RB, da Rocha JB (2011) Diphenyl diselenide induces apoptotic cell death and modulates ERK1/2 phosphorylation in human neuroblastoma SH-SY5Y cells. Arch Toxicol 85:645–651Google Scholar
  359. Powis G, Oblong JE, Gasdaska PY, Berggren M, Hill SR, Kirkpatrick DL (1994) The thioredoxin thioredoxin reductase redox system and control of cell-growth. Oncol Res 6:539–544PubMedGoogle Scholar
  360. Prigol M, Wilhelm EA, Schneider CC, Rocha JBT, Nogueira CW, Zeni G (2007) Involvement of oxidative stress in seizures induced by diphenyl diselenide in rat pups. Brain Res 147:226–232CrossRefGoogle Scholar
  361. Prigol M, Brüning CA, Godoi B, Nogueira CW, Zeni G (2009a) m-Trifluoromethyl-diphenyl diselenide attenuates pentylenetetrazole-induced seizures in mice by inhibiting GABA uptake in cerebral cortex slices. Pharmacol Rep 61:1127–1133PubMedGoogle Scholar
  362. Prigol M, Bruning CA, Zeni G, Nogueira CW (2009b) Protective effect of disubstituted diaryl diselenides on cerebral oxidative damage caused by sodium nitroprusside. Biochem Eng J 45:94–99CrossRefGoogle Scholar
  363. Prigol M, Luchese C, Nogueira CW (2009c) Antioxidant effect of diphenyl diselenide on oxidative stress caused by acute physical exercise in skeletal muscle and lungs of mice. Cell Biochem Funct 27:216–222PubMedCrossRefGoogle Scholar
  364. Prigol M, Schumacher RF, Nogueira CW, Zeni G (2009d) Convulsant effect of diphenyl diselenide in rats and mice and its relationship to plasma levels. Toxicol Lett 189:35–39PubMedCrossRefGoogle Scholar
  365. Prigol M, Pinton S, Schumacher R, Nogueira CW, Zeni G (2010) Convulsant action of diphenyl diselenide in rat pups: measurement and correlation with plasma, liver and brain levels of compound. Arch Toxicol 84:373–378PubMedCrossRefGoogle Scholar
  366. Pritsos CA, Sokoloff M, Gustafson DL (1992) PZ-51 (Ebselen) in vivo protection against Adriamycin- induced mouse cardiac and hepatic lipid peroxidation and toxicity. Biochem Pharmacol 44:839–841PubMedCrossRefGoogle Scholar
  367. Prokopczyk B, Cox JE, Upadhyaya P, Amin S, Desai D, Hoffmann D, El-Bayoumy K (1996) Effects of dietary 1, 4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats. Carcinogenesis 17:749–753PubMedCrossRefGoogle Scholar
  368. Prokopczyk B, Amin S, Desai DH, Kurtzke C, Upadhyaya P, El-Bayoumy K (1997) Effects of 1, 4-phenylenebis(methylene)selenocyanate and selenomethionine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung. Carcinogenesis 18:1855–1857PubMedCrossRefGoogle Scholar
  369. Prokopczyk B, Rosa JG, Desai D, Amin S, Sohn OS, Fiala ES, El-Bayoumy K (2000) Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1, 4-phenylenebis(methylene)selenocyanate. Cancer Lett 161:35–46PubMedCrossRefGoogle Scholar
  370. Puntel RL, Roos DH, Paixao MW, Braga AL, Zeni G, Nogueira CW, Rocha JBT (2007) Oxalate modulates thiobarbituric acid reactive species (TBARS) production in supernatants of homogenates from rat brain, liver and kidney: effect of diphenyl diselenide and diphenyl ditelluride. Chem Biol Interact 165:87–98PubMedCrossRefGoogle Scholar
  371. Puntel RL, Roos DH, Folmer V, Nogueira CW, Galina A, Aschner M, Rocha JBT (2010) Mitochondrial dysfunction induced by different organochalchogens is mediated by thiol oxidation and is not dependent of the classical mitochondrial permeability transition pore opening. Toxicol Sci 117:133–143PubMedCrossRefGoogle Scholar
  372. Quadrani DA, Spiller HA, Steinhorn D (2000) A fatal case of Gun Blue ingestion in a toddler. Vet Hum Toxicol 42:96–98PubMedGoogle Scholar
  373. Rafferty TS, Green MH, Lowe JE, Arlett C, Hunter JA, Beckett GJ, McKenzie RC (2003) Effects of selenium compounds on induction of DNA damage by broadband ultraviolet radiation in human keratinocytes. Br J Dermatol 148:1001–1009PubMedCrossRefGoogle Scholar
  374. Raich PC, Lu J, Thompson HJ, Combs GF Jr (2001) Selenium in cancer prevention: clinical issues and implications. Cancer Invest 19:540–553PubMedCrossRefGoogle Scholar
  375. Ramakrishnan N, Kalinich JF, McClain DE (1996) Ebselen inhibition of apoptosis by reduction of peroxides. Biochem Pharmacol 51:1443–1451PubMedCrossRefGoogle Scholar
  376. Rao CV, Cooma I, Rodriguez JG, Simi B, El-Bayoumy K, Reddy BS (2000) Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1, 4-phenylene bis(methylene)selenocyanate. Carcinogenesis 21:617–621PubMedCrossRefGoogle Scholar
  377. Rayman MP (2000) The importance of selenium to human health. Lancet 356:233–241PubMedCrossRefGoogle Scholar
  378. Rayman MP (2008) Food-chain selenium and human health: emphasis on intake. Br J Nutr 100:254–268PubMedGoogle Scholar
  379. Reddy BS (2000) Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev 9:239–247PubMedGoogle Scholar
  380. Reddy BS, Tanaka T, El-Bayoumy KJ (1985a) Selenium in chemoprevention of carcinogenesis.2. Inhibitory effect of dietary para-methoxybenzeneselenol on azoxymethane-induced colon and kidney carcinogenesis in female F344 rats. Natl Cancer Inst 74:1325–1328Google Scholar
  381. Reddy BS, Tanaka T, Simi B (1985b) Effect of different levels of dietary trans fat or corn-oil on azoxymethane-induced colon carcinogenesis in f344 rats. J Natl Cancer Inst 75:791–798PubMedGoogle Scholar
  382. Reddy BS, Sugie S, Maruyama H, El-Bayoumy K, Marra P (1987) Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Cancer Res 47:5901–5904PubMedGoogle Scholar
  383. Reddy BS, Rivenson A, Kulkarni N, Upadhyaya P, El-Bayoumy K (1992) Selenium in chemoprevention of carcinogenesis.14. chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1, 4-phenylenebis(methylene)selenocyanate. Cancer Res 52:5635–5640PubMedGoogle Scholar
  384. Reddy BS, Rivenson A, El-Bayoumy K, Upadhyaya P, Pittman B, Rao CV (1997) Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets. J Natl Cancer Inst 89:506–512PubMedCrossRefGoogle Scholar
  385. Reddy BS, Hirose Y, Lubet RA, Steele VE, Kelloff GJ, Rao CV (2000) Lack of chemopreventive efficacy of DL-selenomethionine in colon carcinogenesis. Int J Mol Med 5:327–330PubMedGoogle Scholar
  386. Ren XJ, Jemth P, Board PG, Luo GM, Mannervik B, Liu JQ, Zhang K, Shen JC (2002) A semisynthetic glutathione peroxidase with high catalytic efficiency: selenoglutathione transferase. Chem Biol 9:789–794PubMedCrossRefGoogle Scholar
  387. Richie JP Jr, Kleinman W, Desai DH, Das A, Amin SG, Pinto JT, El-Bayoumy K (2006) The organoselenium compound 1, 4-phenylenebis(methylene)selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorgenesis and enhances glutathione-related antioxidant levels in A/J mouse lung. Chem Biol Interact 161:93–103PubMedCrossRefGoogle Scholar
  388. Rocha JBT, Gabriel D, Zeni G, Posser T, Siqueira L, Nogueira CW, Folmer V (2005) Ebselen and diphenyl diselenide change biochemical hepatic responses to overdosage with paracetamol. Environ Toxicol Pharmacol 19:255–261PubMedCrossRefGoogle Scholar
  389. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457–467PubMedCrossRefGoogle Scholar
  390. Rooseboom M, Commandeur JNM, Floor GC, Rettie AE, Vermeulen NPE (2001) Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates. Chem Res Toxicol 14:127–134PubMedCrossRefGoogle Scholar
  391. Rosa JG, Prokopczyk B, Desai DH, Amin SG, El-Bayoumy K (1998) Elevated 8-hydroxy-2′-deoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and inhibition by dietary 1, 4-phenylenebis(methylene)selenocyanate. Carcinogenesis 19:1783–1788PubMedCrossRefGoogle Scholar
  392. Rosa RM, Flores DG, Appelt HR, Braga AL, Henriques JA, Roesler R (2003) Facilitation of long-term object recognition memory by pretraining administration of diphenyl diselenide in mice. Neurosci Lett 341:217–220Google Scholar
  393. Rosa RM, Sulzbacher K, Picada JN, Roesler R, Saffi J, Brendel M, Henriques JAP (2004) Genotoxicity of diphenyl diselenide in bacteria and yeast. Mutat Res 563:107–115PubMedGoogle Scholar
  394. Rosa RM, Oliveira RB, Saffi J, Braga AL, Roesler R, Dal-Pizzol F, Moreira JCF, Brendel M, Henriques JAP (2005) Pro-oxidant action of diphenyl diselenide in the yeast Saccharomyces cerevisiae exposed to ROS-generating conditions. Life Sci 77:2398–2411CrossRefGoogle Scholar
  395. Rosa RM, Hoch NC, Furtado GV, Saffi J, Henriques JAP (2007a) DNA damage in tissues and organs of mice treated with diphenyl diselenide. Mutat Res 633:35–45PubMedGoogle Scholar
  396. Rosa RM, Moura DJ, Silva ACR, Saffi J, Henriques JAP (2007b) Antioxidant activity of diphenyl diselenide prevents the genotoxicity of several mutagens in Chinese hamster V79 cells. Mutat Res 631:44–54PubMedGoogle Scholar
  397. Rosa RM, Picada JN, Saffi J, Henriques JAP (2007c) Cytotoxic, genotoxic, and mutagenic effects of diphenyl diselenide in Chinese hamster lung fibroblasts. Mutat Res 628:87–98PubMedGoogle Scholar
  398. Rosa RM, Guecheva TN, Oliveira IM, Braga AL, Henriques JAP (2010) Genetic toxicity of three symmetrical diselenides in yeast. J Braz Chem Soc 21:2119–2124CrossRefGoogle Scholar
  399. Rossato JI, Zeni G, Mello CF, Rubin MA, Rocha JBT (2002a) Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci Lett 318:137–140PubMedCrossRefGoogle Scholar
  400. Rossato JI, Ketzer LA, Centuriao FB, Silva SJN, Ludtke DS, Zeni G, Braga AL, Rubin MA, Rocha JBT (2002b) Antioxidant properties of new chalcogenides against lipid peroxidation in rat brain. Neurochem Res 27:297–303PubMedCrossRefGoogle Scholar
  401. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium—biochemical role as a component of glutathione peroxidase. Science 179:588–590PubMedCrossRefGoogle Scholar
  402. Roussyn I, Briviba K, Masumoto H, Sies H (1996) Selenium-containing compounds protect DNA from single-strand breaks caused by peroxynitrite. Arch Biochem Biophys 330:216–218PubMedCrossRefGoogle Scholar
  403. Saad SY, Najjar TA, Arafah MM (2006) Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats. Basic Clin Pharmacol Toxicol 99:412–417PubMedCrossRefGoogle Scholar
  404. Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H, Ohta T, Ishibashi S (1998) Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 42:269–277PubMedCrossRefGoogle Scholar
  405. Sakurai T, Kanayama M, Shibata T, Itoh K, Kobayashi A, Yamamoto M, Uchida K (2006) Ebselen, a seleno-organic antioxidant, as an electrophile. Chem Res Toxicol 19:1196–1204PubMedCrossRefGoogle Scholar
  406. Salom JB, Perez-Asensio FJ, Burguete MC, Marin N, Pitarch C, Torregrosa G, Romero FJ, Alborch E (2004) Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia. Eur J Pharmacol 495:55–62PubMedCrossRefGoogle Scholar
  407. Saluk-Juszczak J, Wachowicz B, Wojtowicz H, Kloc K, Bald E, Glowacki R (2006) Novel selenoorganic compounds as modulators of oxidative stress in blood platelets. Cell Biol Toxicol 22:323–329PubMedCrossRefGoogle Scholar
  408. Santos DB, Schiar VPP, Paixao MW, Meinerz DF, Nogueira CW, Aschner M, Rocha JBT, Barbosa NBV (2009a) Hemolytic and genotoxic evaluation of organochalcogens in human blood cells in vitro. Toxicol In Vitro 23:1195–1204PubMedCrossRefGoogle Scholar
  409. Santos DB, Schiar VPP, Ribeiro MCP, Schwab RS, Meinerz DF, Allebrandt J, Rocha JBT, Nogueira CW, Aschner M, Barbosa NBV (2009b) Genotoxicity of organoselenium compounds in human leukocytes in vitro. Mutat Res 676:21–26PubMedGoogle Scholar
  410. Sarker KP, Biswas KK, Rosales JL, Yamaji K, Hashiguchi T, Lee KY, Maruyama I (2003) Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2. J Neurochem 87:1345–1353PubMedCrossRefGoogle Scholar
  411. Sarma BK, Mugesh G (2005) Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions. J Am Chem Soc 127:11477–11485PubMedCrossRefGoogle Scholar
  412. Sarma BK, Mugesh G (2008) Antioxidant activity of the anti-inflammatory compound ebselen: a reversible cyclization pathway via selenenic and seleninic acid intermediates. Chem Eur J 14:10603–10614CrossRefGoogle Scholar
  413. Satoh T, Ishige K, Sagara YS (2004) Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps. Neurosci Lett 371:1–5PubMedCrossRefGoogle Scholar
  414. Savegnago L, Jesse CR, Moro AV, Borges VC, Santos FW, Rocha JBT, Nogueira CW (2006a) Bis selenide alkene derivatives: a class of potential antioxidant and antinociceptive agents. Pharmacol Biochem Behav 83:221–229PubMedCrossRefGoogle Scholar
  415. Savegnago L, Trevisan M, Alves D, Rocha JBT, Nogueira CW, Zeni G (2006b) Antisecretory and antiulcer effects of diphenyl diselenide. Environ Toxicol Pharmacol 21:86–92PubMedCrossRefGoogle Scholar
  416. Savegnago L, Jesse CR, Pinto LG, Rocha JBT, Nogueira CW (2007a) Diphenyl diselenide attenuates acute thermal hyperalgesia and persistent inflammatory and neuropathic pain behavior in mice. Brain Res 1175:54–59PubMedCrossRefGoogle Scholar
  417. Savegnago L, Jesse CR, Pinto LG, Rocha JBT, Nogueira CW, Zeni G (2007b) Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog Neuro Psychopharmacol Biol Psychiatry 31:1261–1269CrossRefGoogle Scholar
  418. Savegnago L, Pinto LG, Jesse CR, Alves D, Rocha JBT, Nogueira CW, Zeni G (2007c) Antinociceptive properties of diphenyl diselenide: evidences for the mechanism of action. Eur J Pharmacol 555:129–138PubMedCrossRefGoogle Scholar
  419. Savegnago L, Pinto LG, Jesse CR, Rocha JBT, Nogueira CW, Zeni G (2007d) Spinal mechanisms of antinociceptive action caused by diphenyl diselenide. Brain Res 1162:32–37PubMedCrossRefGoogle Scholar
  420. Savegnago L, Jesse CR, Nogueira CW (2008a) Caffeine and a selective adenosine A(2B) receptor antagonist but not imidazoline receptor antagonists modulate antinociception induced by diphenyl diselenide in mice. Neurosci Lett 436:120–123PubMedCrossRefGoogle Scholar
  421. Savegnago L, Jesse CR, Pinto LG, Rocha JBT, Barancelli DA, Nogueira CW, Zeni G (2008b) Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action. Pharmacol Biochem Behav 88:418–426PubMedCrossRefGoogle Scholar
  422. Savegnago L, Jesse CR, Santos ARS, Rocha JBT, Nogueira CW (2008c) Mechanisms involved in the antinociceptive effect caused by diphenyl diselenide in the formalin test. J Pharm Pharmacol 60:1679–1686PubMedCrossRefGoogle Scholar
  423. Savegnago L, Jesse CR, Nogueira CW (2009) Structural modifications into diphenyl diselenide molecule do not cause toxicity in mice. Environ Toxicol Pharm 27:271–276CrossRefGoogle Scholar
  424. Schalkwijk J, Vandenberg WB, Vandeputte LBA, Joosten LAB (1986) An experimental model for hydrogen peroxide—induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues. Arthr Rheum 29:532–538CrossRefGoogle Scholar
  425. Schellmann B, Raithel HJ, Schaller KH (1986) Acute fatal selenium poisoning—toxicological and occupational medical aspects. Arch Toxicol 59:61–63PubMedCrossRefGoogle Scholar
  426. Schewe C, Schewe T, Wendel A (1994) Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione. Biochem Pharmacol 48:65–74PubMedCrossRefGoogle Scholar
  427. Schiar VPP, dos Santos DB, Paixão MW, Nogueira CW, Rocha JBT, Zeni G (2009) Human erythrocyte hemolysis induced by selenium and tellurium compounds increased by GSH or glucose: a possible involvement of reactive oxygen species. Chem Biol Interact 177:28–33PubMedCrossRefGoogle Scholar
  428. Schrauzer GN, Surai PF (2009) Selenium in human and animal nutrition: resolved and unresolved issues. A partly historical treatise in commemoration of the fiftieth anniversary of the discovery of the biological essentiality of selenium, dedicated to the memory of Klaus Schwarz (1914–1978) on the occasion of the thirtieth anniversary of his death. Crit Rev Biotechnol 29:2–9PubMedCrossRefGoogle Scholar
  429. Schuh B, Jappe U (2007) Selenium intoxication: undesirable effect of a fasting cure. Br J Dermatol 156:177–178PubMedCrossRefGoogle Scholar
  430. Schwarz K, Fredga A (1969) Biological potency of organic selenium compounds I. Aliphatic monoseleno- and diseleno-dicarboxylic acids. J Biol Chem 244:2103–2110Google Scholar
  431. Schwarz K, Foltz CM (1957) Selenium is an integral part of factor-3 against dietary necrotic liver degeneration. J Am Chem Soc 79:3292–3293CrossRefGoogle Scholar
  432. Seko Y, Saito Y, Kitahara J, Imura N (1989) Selenium in biology and medicine. In: Wendel A (ed) Springer, Berlin, pp 70–73Google Scholar
  433. Seo YR, Kelley MR, Smith ML (2002) Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA 99:14548–14553PubMedCrossRefGoogle Scholar
  434. Seo JY, Lee CH, Cho JH, Choi JH, Yoo KY, Kim DW, Park OK, Li H, Choi SY, Hwang IK, Won MH (2009) Neuroprotection of ebselen against ischemia/reperfusion injury involves GABA shunt enzymes. J Neurol Sci 285:88–94PubMedCrossRefGoogle Scholar
  435. Shamberger RJ (1981) Selenium in the environment. Sci Tot Environ 17:59–74CrossRefGoogle Scholar
  436. Shamberger RJ, Frost DV (1969) Possible protective effect of selenium against human cancer. Can Med Assoc J 100:682–685PubMedGoogle Scholar
  437. Shen HM, Yang CF, Ding WX, Liu J, Ong CN (2001a) Superoxide radical-initiated apoptotic signalling pathway in selenite-treated HEPG(2) cells: Mitochondria serve as the main target. Free Radic Biol Med 30:9–21PubMedCrossRefGoogle Scholar
  438. Shen CL, Song W, Pence BC (2001b) Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes. Cancer Epidemiol Biomarkers Prev 10:385–390PubMedGoogle Scholar
  439. Shen LL, Shin KM, Lee KT, Jeong JH (2004) Synthesis of new diselenide compounds as antiinflammatory agents. Arch Pharm Res 27:816–819PubMedCrossRefGoogle Scholar
  440. Sher L (2000) Selenium and human health. Lancet 356:943–944PubMedCrossRefGoogle Scholar
  441. Sher L (2007) Possible role of selenium deficiency in the neurobiology of depression and suicidal behavior in patients with alcohol use disorders. Int Disabil Human Development 6:227–230CrossRefGoogle Scholar
  442. Shi H, Liu S, Miyake M, Liu KJ (2006) Ebselen induced C6 glioma cell death in oxygen and glucose deprivation. Chem Res Toxicol 19:655–660PubMedCrossRefGoogle Scholar
  443. Shimohashi N, Nakamuta M, Uchimura K, Sugimoto R, Iwamoto H, Enjoji M, Nawata H (2000) Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of Jun-N-terminal kinase and the NF-kappa B signaling pathway in rat Kupffer cells. J Cell Biochem 78:595–606PubMedCrossRefGoogle Scholar
  444. Short MD, Xie Y, Li L, Cassidy PB, Roberts JC (2003) Characteristics of selenazolidine prodrugs of selenocysteine: toxicity and glutathione peroxidase induction in V79 cells. J Med Chem 46:3308–3313PubMedCrossRefGoogle Scholar
  445. Sies H, Masumoto H (1997) Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv Pharmacol 38:229–246PubMedCrossRefGoogle Scholar
  446. Sies H, Klotz LO, Sharov VS, Assmann A, Briviba K (1998) Protection against peroxynitrite by selenoproteins. Z Naturforsch 53:228–232Google Scholar
  447. Sinha R, Medina D (1997) Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Carcinogenesis 18:1541–1547PubMedCrossRefGoogle Scholar
  448. Sinha R, Kiley SC, Lu JX, Thompson HJ, Moraes R, Jaken S, Medina D (1999) Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Cancer Lett 146:135–145PubMedCrossRefGoogle Scholar
  449. Soares FA, Farina M, Boettcher AC, Braga AL, Rocha JBT (2005) Organic and inorganic forms of selenium inhibited differently fish (Rhamdia quelen) and rat (Rattus norvergicus albinus) delta-aminolevulinate dehydratase. Environ Res 98:46–54CrossRefGoogle Scholar
  450. Sohn OS, Blackwell L, Mathis J, Asaad WW, Reddy BS, El-Bayoumy K (1991) Excretion and tissue distribution of selenium following treatment of male F344 rats with benzylselenocyanate or sodium selenite. Drug Metab Dispos 19:865–870PubMedGoogle Scholar
  451. Soni MG, Thurmond TS, Miller ER, Spriggs T, Bendich A, Omaye ST (2010) Safety of vitamins and minerals: controversies and perspective. Toxicol Sci 118:348–355PubMedCrossRefGoogle Scholar
  452. Spallholz JE (1994) On the nature of selenium toxicity and carcinostatic activity. Free Rad Biol Med 17:45–64PubMedCrossRefGoogle Scholar
  453. Spallholz JE, Palace VP, Reid TW (2004) Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Biochem Pharmacol 67:547–554PubMedCrossRefGoogle Scholar
  454. Spiller HA, Pfiefer E (2007) Two fatal cases of selenium toxicity. Forensic Sci Int 171:67–72PubMedCrossRefGoogle Scholar
  455. Stadtman TC (1996) Selenocysteine. Ann Rev Biochem 65:83–100PubMedCrossRefGoogle Scholar
  456. Stangherlin EC, Luchese C, Pinton S, Rocha JBT, Nogueira CW (2008) Sub-chronical exposure to diphenyl diselenide enhances acquisition and retention of spatial memory in rats. Brain Res 1201:106–113PubMedCrossRefGoogle Scholar
  457. Stapleton SR (2000) Selenium: an insulin-mimetic. Cell Mol Life Sci 57:1874–1879PubMedCrossRefGoogle Scholar
  458. Stewart MS, Spallholz JE, Neldner KH, Pence BC (1998) Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Rad Biol Med 26:42–48CrossRefGoogle Scholar
  459. Stock T, Rother M (2009) Selenoproteins in Archaea and Gram-positive bacteria. Biochem Biophys Acta Gen Subj 1790:1520–1532CrossRefGoogle Scholar
  460. Straliotto MR, Mancini G, de Oliveira J, Nazari EM, Müller YM, Dafre A, Ortiz S, Silva EL, Farina M, Latini A, Rocha JB, de Bem AF (2010) Acute exposure of rabbits to diphenyl diselenide: a toxicological evaluation. J Appl Toxicol 30:761–768PubMedCrossRefGoogle Scholar
  461. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Reid ME (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Int Med 147:217–223PubMedGoogle Scholar
  462. Stranges S, Sieri S, Vinceti M, Grioni S, Guallar E, Laclaustra M, Muti P, Berrino F, Krogh V (2010) A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Pub Health 10:564CrossRefGoogle Scholar
  463. Sugie S, Tanaka T, El-Bayoumy K (2000) Chemoprevention of carcinogenesis by organoselenium compounds. J Health Sci 46:422–425Google Scholar
  464. Sui H, Wang W, Wang PH, Liu LS (2005) Protective effect of antioxidant ebselen (PZ51) on the cerebral cortex of stroke-prone spontaneously hypertensive Rats. Hypertens Res 28:249–254PubMedCrossRefGoogle Scholar
  465. Sutter ME, Thomas JD, Brown J, Morgan B (2008) Selenium toxicity: a case of selenosis caused by a nutritional supplement. Ann Int Med 148:970–971PubMedGoogle Scholar
  466. Tabuchi Y, Kurebayashi Y (1993) Antisecretory and antiul- cer effects of ebselen, a seleno-organic compound, in rats. Jpn J Pharmacol 61:255–257PubMedCrossRefGoogle Scholar
  467. Tabuchi Y, Ogasawara T, Furuhama K (1994) Mechanism of the inhibition of hog gastric (H+, Kt)-ATPase by the seleno-organic compound ebselen. Drug Res 44:51–54Google Scholar
  468. Tabuchi Y, Sugiyama N, Horiuchi T, Furusawa M, Furuhama K (1995) Ebselen, a seleno-organic compound, protects against ethanol-induced murine gastric mucosal injury in both in vivo and in vitro systems. Eur J Pharmacol 272:195–201PubMedCrossRefGoogle Scholar
  469. Takasago T, Peters EE, Graham DI, Masayasu H, Macrae IM (1997) Neuroprotective efficacy of ebselen, an anti-oxidant with antiinflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br J Pharmacol 122:1251–1256PubMedCrossRefGoogle Scholar
  470. Tamasi V, Jeffries JM, Arteel GE, Falkner KC (2004) Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription. Arch Biochem Biophys 431:161–168PubMedCrossRefGoogle Scholar
  471. Tanaka T, Reddy BS, El-Bayoumy K (1985) Selenium in chemoprevention of carcinogenesis.3. Inhibition by dietary organoselenium, para-methoxybenzeneselenol, of hepatocarcinogenesis induced by azoxymethane in rats. Jpn J Cancer Res 76:462–467PubMedGoogle Scholar
  472. Tanaka T, Makita H, Kawabata K, Mori H, El-Bayoumy K (1997) 1, 4-Phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Cancer Res 57:3644–3648PubMedGoogle Scholar
  473. Tanaka T, Kohno H, Murakami M, Kagami S, El-Bayoumy K (2000) Suppressing effects of dietary supplementation of the organoselenium 1, 4-phenylenebis(methylene)selenocyanate and the Citrus antioxidant auraptene on lung metastasis of melanoma cells in mice. Cancer Res 60:3713–3716PubMedGoogle Scholar
  474. Tapiero H, Townsend DM, Tew KD (2003) The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 57:134–144PubMedCrossRefGoogle Scholar
  475. Tchoumkeu-Nzouessa GC, Rebel G (1998) Differential effect of ebselen on compound 48/80- and anti-IgE-induced histamine release from rat peritoneal mast cells. Biochem Pharmacol 56:1525–1528PubMedCrossRefGoogle Scholar
  476. Tianfeng C, Yum-Shing W (2009) Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells. Biomed Pharmacother 63:105–113CrossRefGoogle Scholar
  477. Tiano L, Fedeli D, Santoni G, Davies I, Wakabayashi T, Falcioni G (2003) Ebselen prevents mitochondrial ageing due to oxidative stress: in vitro study of fish erythrocytes. Mitochondrion 2:428–436PubMedCrossRefGoogle Scholar
  478. Tripathi SK, Patel U, Roy D, Sunoj RB, Singh HB, Wolmersha G, Butcher RJ (2005) o-Hydroxylmethylphenylchalcogens: synthesis, intramolecular nonbonded chalcogen. OH interactions, and glutathione peroxidase-like activity. J Org Chem 70:9237–9247PubMedCrossRefGoogle Scholar
  479. Trumbo PR (2005) The level of evidence for permitting a qualified health claim: FDA’s review of the evidence for selenium and cancer and vitamin E and heart disease. J Nutr 135:354–356PubMedGoogle Scholar
  480. Tsen CC, Tappel AL (1958) Catalytic oxidation of glutathione and other sulfhydryl compounds by selenite. J Biol Chem 233:1230–1232PubMedGoogle Scholar
  481. Tunc T, Uysal B, Atabek C, Kesik V, Caliskan B, Oztas E, Ersoz N, Oter S, Guven A (2009) Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res 155:210–216PubMedCrossRefGoogle Scholar
  482. Unni E, Singh U, Ganther HE, Sinha R (2001) Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro. Biofactors 14:169–177PubMedCrossRefGoogle Scholar
  483. Unni E, Koul D, Yung WKA, Sinha R (2005) Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro. Breast Cancer Res 7:R699–R707PubMedCrossRefGoogle Scholar
  484. Valdiglesias V, Pasaro E, Mendez J, Laffon B (2010) In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: a review. Arch Toxicol 84:337–351PubMedCrossRefGoogle Scholar
  485. Venhorst J, Rooseboom M, Vermeulen NP, Commandeur JN (2003) Studies on the inhibition of human cytochromes P450 by selenocysteine Se-conjugates. Xenobiotica 33:57–72PubMedCrossRefGoogle Scholar
  486. Vinceti M, Guidetti D, Pinotti M, Rovesti S, Merlin M, Vescovi L, Bergomi M, Vivoli G (1996) Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content. Epidemiology 7:529–532PubMedCrossRefGoogle Scholar
  487. Vinceti M, Rothman KJ, Bergomi M, Borciani N, Serra L, Vivoli G (1998) Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Can Epidemiol Biomarkers Prev 7:853–856Google Scholar
  488. Vinceti M, Rovesti S, Bergomi M, Vivoli G (2000) The epidemiology of selenium and human cancer. Tumori 86:105–118PubMedGoogle Scholar
  489. Vinceti M, Wei ET, Malagoli C, Bergomi M, Vivoli G (2001) Adverse health effects of selenium in humans. Rev Environ Health 16:233–251PubMedCrossRefGoogle Scholar
  490. Vinceti M, Maraldi T, Bergomi M, Malagoli C (2009) Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry. Rev Environ Health 24:231–248PubMedCrossRefGoogle Scholar
  491. Vinceti M, Bonvicini F, Rothman KJ, Vescovi L, Wang F (2010) The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study. Environ Health 9:77PubMedCrossRefGoogle Scholar
  492. Von Pressentin MM, El-Bayoumy K, Guttenplan JB (2000) Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (MutaMouse) and the effects of 1, 4-phenylenebis(methylene)selenocyanate. Mutat Res 466:71–78Google Scholar
  493. Wallenberg M, Olm E, Hebert C, Bjornstedt M, Fernandes AP (2010) Selenium compounds are substrates for glutaredoxins: a novel pathway for selenium metabolism and a potential mechanism for selenium-mediated cytotoxicity. Biochem J 429:85–93PubMedCrossRefGoogle Scholar
  494. Wang T, Liu B, Qin L, Wilson B, Hong JS (2004) Protective effect of the SOD/catalase mimetic MnTMPyP on inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronal-glial cultures. J Neuroimmunol 147:68–72PubMedCrossRefGoogle Scholar
  495. Wasser S, Lim GY, Ong CN, Tan CE (2001) Anti-oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats. J Gastroenterol Hepatol 16:1244–1253PubMedCrossRefGoogle Scholar
  496. Watanabe T, Nishiyama M, Hori T, Asano T, Shimizu T, Masayasu H (1997) Ebselen (DR3305) ameliorates delayed cerebral vasospasm in a canine two-hemorrhage model. Neurol Res 19:563–565PubMedGoogle Scholar
  497. Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, Fan JH, Gunter EW, Taylor PR, Mark SD (2004) Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79:80–85PubMedGoogle Scholar
  498. Wendel A, Tiegs G (1986) A novel biologically active seleno-organic compound–VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 35:2115–2118PubMedCrossRefGoogle Scholar
  499. Wendel A, Fausel M, Safayhi H, Tiegs G, Otter R (1984) A novel biologically active seleno-organic compound-II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem Pharmacol 33:3241–3246PubMedCrossRefGoogle Scholar
  500. Whanger PD (2004) Selenium and its relationship to cancer: an update. Brit J Nutr 91:11–28PubMedCrossRefGoogle Scholar
  501. Wilhelm EA, Jesse CR, Leite MR, Nogueira CW (2009a) Studies on preventive effects of diphenyl diselenide on acetaminophen-induced hepatotoxicity in rats. Pathophysiology 16:31–37PubMedCrossRefGoogle Scholar
  502. Wilhelm EA, Jesse CR, Nogueira CW (2009b) Protective effect of p-methoxyl-diphenyl diselenide in lethal acute liver failure induced by lipopolysaccharide and d-galactosamine in mice. Fundam Clin Pharmacol 23:727–734PubMedCrossRefGoogle Scholar
  503. Wilhelm EA, Jesse CR, Nogueira CW, Savegnago L (2009c) Introduction of trifluoromethyl group into diphenyl diselenide molecule alters its toxicity and protective effect against damage induced by 2-nitropropane in rats. Exp Toxicol Pathol 61:197–203PubMedCrossRefGoogle Scholar
  504. Wilhelm EA, Jesse CR, Bortolatto CF, Barbosa NBV, Nogueira CW (2010) Evidence of the involvement of K+ channels and PPARγ receptors in the antidepressant-like activity of diphenyl diselenide in mice. J Pharm Pharmacol 62:1121–1127PubMedCrossRefGoogle Scholar
  505. Wilhelm EA, Jesse CR, Bortolatto CF, Nogueira CW (2011) (E)-2-benzylidene-4-phenyl-1, 3-diselenole has antioxidant and hepatoprotective properties against oxidative damage induced by 2-nitropropane in rats. Fund Clin Pharmacol 25:80–90CrossRefGoogle Scholar
  506. Wilson SR, Zucker PA, Huang RRC, Spector A (1989) A development of synthetic compounds with glutathione peroxidase activity. J Am Chem Soc 111:5936–5939CrossRefGoogle Scholar
  507. Wirth T (1998) Glutathione peroxidase-like activities of oxygen-containing diselenides. Molecules 3:164–166Google Scholar
  508. Wood-Allum CA, Barber SC, Kirby J, Heath P, Holden H, Mead R, Higginbottom A, Allen S, Beaujeux T, Alexson SE, Ince PG, Shaw PJ (2006) Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain 129:1693–1709PubMedCrossRefGoogle Scholar
  509. Woznichak MM, Overcast JD, Robertson K, Neumann HM, May SW (2000) Reaction of phenylaminoethyl selenides with peroxynitrite and hydrogen peroxide. Arch Biochem Biophys 379:314–320PubMedCrossRefGoogle Scholar
  510. Xiang N, Zhao R, Zhong WX (2009) Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells. Can Chem Pharmacol 63:351–362CrossRefGoogle Scholar
  511. Xiao H, Parkin KL (2006) Induction of Phase II enzyme activity by various selenium compounds. Nut Cancer Int J 55:210–223CrossRefGoogle Scholar
  512. Xiong S, Markesbery WR, Shao C, Lovell MA (2007) Seleno-l-methionine protects against β-amyloid and iron/hydrogen peroxide-mediated neuron death. Antioxid Redox Signal 9:457–467PubMedCrossRefGoogle Scholar
  513. Xu JH, Hu HT, Liu Y, Qian YH, Liu ZH, Tan QR, Zhang ZJ (2006) Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons. Neurosci Lett 399:210–214PubMedCrossRefGoogle Scholar
  514. Yamagata K, Ichinose S, Miyashita A, Atagami M (2008) Protective effects of ebselen, a seleno-organic antioxidant on neurodegeneration induced by hypoxia and reperfusion in stroke-prone spontaneously hypertensive rat. Neuroscience 153:428–435PubMedCrossRefGoogle Scholar
  515. Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H (1998) Ebselen in acute ischemic stroke-A placebo-controlled, double-blind clinical trial. Stroke 29:12–17PubMedCrossRefGoogle Scholar
  516. Yamasoba T, Pourbakht A, Sakamoto T, Suzuki M (2005) Ebselen prevents noise-induced excitotoxicity and temporary threshold shift. Neurosci Lett 380:234–238PubMedCrossRefGoogle Scholar
  517. Yang CF, Shen HM, Ong CN (2000a) Ebselen induces apoptosis in HepG(2) cells through rapid depletion of intracellular thiols. Arch Biochem Biophys 374:142–152PubMedCrossRefGoogle Scholar
  518. Yang CF, Shen HM, Ong CN (2000b) Intracellular thiol depletion causes mitochondrial permeability transition in ebselen-induced apoptosis. Arch Biochem Biophys 380:319–330PubMedCrossRefGoogle Scholar
  519. Yang Y, Huang F, Ren Y, Xing L, Wu Y, Li ZS, Pan HZ, Xu CM (2009) The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice. Oncol Res 18:1–8PubMedCrossRefGoogle Scholar
  520. Yoshida M, Iizuka K, Terada A, Hara M, Nishijima H, Shimada A, Nakada K, Satoh Y, Akama Y (2000) Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats. Tohoku J Exp Med 191:209–220PubMedCrossRefGoogle Scholar
  521. Yoshizumi M, Kogame T, Suzaki Y, Fujita Y, Kyat M, Dirima K, Ishizawa K, Tsuchiya K, Kagami S, Tamaki T (2002) Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells. Br J Pharmacol 136:1023–1032PubMedCrossRefGoogle Scholar
  522. Zade SS, Panda S, Tripathi SK, Singh HB, Wolmershauser G (2004) Convenient synthesis, characterization and GPx-like catalytic activity of novel ebselen derivatives. Eur J Org Chem 18:3857–3864CrossRefGoogle Scholar
  523. Zasso FB, Goncales CEP, Jung EAC, Araldi D, Zeni G, Rocha JBT, Nogueira CW (2005) On the mechanisms involved in antinociception induced by diphenyl diselenide. Environ Toxicol Pharmacol 19:283–289PubMedCrossRefGoogle Scholar
  524. Zeng H, Combs GF (2008) Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 19:1–7PubMedCrossRefGoogle Scholar
  525. Zeng H, Briske-Anderson M, Idso JP, Hunt CD (2006) The selenium metabolite methylselenol inhibits the migration and invasion potential of HT1080 tumor cells. J Nutr 136:1528–1532PubMedGoogle Scholar
  526. Zhang MJ, Nomura A, Uchida Y, Iijima H, Sakamoto T, Iishii Y, Morishima Y, Mochizuki M, Masuyama K, Hirano K, Sekizawa K (2002) Ebselen suppresses late airway responses and airway inflammation in guinea pigs. Free Radic Bio Med 32:454–464CrossRefGoogle Scholar
  527. Zhang JH, Wang L, Anderson LB, Witthuhn B, Xu YJ, Lu JX (2010) Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model. Cancer Prev Res 3:994–1006CrossRefGoogle Scholar
  528. Zhao R, Holmgren A (2002) A novel antioxidant mechanism of ebselen involving ebselen diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase. J Biol Chem 277:39456–39462PubMedCrossRefGoogle Scholar
  529. Zhao R, Holmgren A (2004) Ebselen is a dehydroascorbate reductase mimic, facilitating the recycling of ascorbate via mammalian thioredoxin systems. Antioxid Redox Signal 6:99–104PubMedCrossRefGoogle Scholar
  530. Zhao R, Masayasu H, Holmgren A (2002) Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc Natl Acad Sci 99:8579–8584PubMedCrossRefGoogle Scholar
  531. Zhao H, Whitfield ML, Xu T, Botstein D, Brooks JD (2004) Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. Mol Biol Cell 15:506–519PubMedCrossRefGoogle Scholar
  532. Zhu YG, Pilon-Smits EAH, Zhao FJ, Williams PN, Meharg AA (2009) Selenium in higher plants: understanding mechanisms for biofortification and phytoremediation. Trends Plant Sci 14:436–442PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Laboratório de Síntese, Reatividade e Avaliacão Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas (CCNE)Universidade Federal de Santa Maria (UFSM)Santa MariaBrazil

Personalised recommendations